<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6680751</article-id><article-id pub-id-type="doi">10.3390/molecules24142631</article-id><article-id pub-id-type="publisher-id">molecules-24-02631</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Terpene Derivatives as a Potential Agent against Antimicrobial Resistance (AMR) Pathogens</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mahizan</surname><given-names>Nik Amirah</given-names></name><xref ref-type="aff" rid="af1-molecules-24-02631">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9275-3653</contrib-id><name><surname>Yang</surname><given-names>Shun-Kai</given-names></name><xref ref-type="aff" rid="af1-molecules-24-02631">1</xref></contrib><contrib contrib-type="author"><name><surname>Moo</surname><given-names>Chew-Li</given-names></name><xref ref-type="aff" rid="af1-molecules-24-02631">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5413-3314</contrib-id><name><surname>Song</surname><given-names>Adelene Ai-Lian</given-names></name><xref ref-type="aff" rid="af2-molecules-24-02631">2</xref></contrib><contrib contrib-type="author"><name><surname>Chong</surname><given-names>Chou-Min</given-names></name><xref ref-type="aff" rid="af3-molecules-24-02631">3</xref></contrib><contrib contrib-type="author"><name><surname>Chong</surname><given-names>Chun-Wie</given-names></name><xref ref-type="aff" rid="af4-molecules-24-02631">4</xref></contrib><contrib contrib-type="author"><name><surname>Abushelaibi</surname><given-names>Aisha</given-names></name><xref ref-type="aff" rid="af5-molecules-24-02631">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5177-0257</contrib-id><name><surname>Lim</surname><given-names>Swee-Hua Erin</given-names></name><xref ref-type="aff" rid="af5-molecules-24-02631">5</xref></contrib><contrib contrib-type="author"><name><surname>Lai</surname><given-names>Kok-Song</given-names></name><xref ref-type="aff" rid="af1-molecules-24-02631">1</xref><xref ref-type="aff" rid="af5-molecules-24-02631">5</xref><xref rid="c1-molecules-24-02631" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Avato</surname><given-names>Pinarosa</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-24-02631"><label>1</label>Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia</aff><aff id="af2-molecules-24-02631"><label>2</label>Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia</aff><aff id="af3-molecules-24-02631"><label>3</label>Department of Aquaculture, Faculty of Agriculture, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia</aff><aff id="af4-molecules-24-02631"><label>4</label>School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia</aff><aff id="af5-molecules-24-02631"><label>5</label>Health Sciences Division, Abu Dhabi Women&#x02019;s College, Higher Colleges of Technology, 41012 Abu Dhabi, UAE</aff><author-notes><corresp id="c1-molecules-24-02631"><label>*</label>Correspondence: <email>laikoksong@upm.edu.my</email>; Tel.: +60-389468021</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2019</year></pub-date><volume>24</volume><issue>14</issue><elocation-id>2631</elocation-id><history><date date-type="received"><day>24</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>03</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The evolution of antimicrobial resistance (AMR) in pathogens has prompted extensive research to find alternative therapeutics. Plants rich with natural secondary metabolites are one of the go-to reservoirs for discovery of potential resources to alleviate this problem. Terpenes and their derivatives comprising of hydrocarbons, are usually found in essential oils (EOs). They have been reported to have potent antimicrobial activity, exhibiting bacteriostatic and bactericidal effects against tested pathogens. This brief review discusses the activity of terpenes and derivatives against pathogenic bacteria, describing the potential of the activity against AMR followed by the possible mechanism exerted by each terpene class. Finally, ongoing research and possible improvisation to the usage of terpenes and terpenoids in therapeutic practice against AMR are discussed.</p></abstract><kwd-group><kwd>terpenes</kwd><kwd>terpenoids</kwd><kwd>antimicrobial resistance</kwd><kwd>synergy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-24-02631"><title>1. Introduction</title><p>The increase of antimicrobial resistance (AMR) in microbiological pathogens has spurred a global mandate to identify potentially effective alternatives [<xref rid="B1-molecules-24-02631" ref-type="bibr">1</xref>]. AMR is defined as inefficacious infection-associated treatment with an antimicrobial agent that used to be effective [<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>]. The rise of AMR is contributed by both intrinsic and extrinsic factors. For instance, evolution of intrinsic factors in microbes include development of structural attributes [<xref rid="B3-molecules-24-02631" ref-type="bibr">3</xref>] such as microbial biofilm production [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>], and insertion of transposons [<xref rid="B5-molecules-24-02631" ref-type="bibr">5</xref>]. On the other hand, extrinsic contributing factors include excessive antibiotic usage resulting from non-judicious prescribing practices, fueled by increased competition in the production and marketing of antimicrobials within the pharmaceutical industry [<xref rid="B6-molecules-24-02631" ref-type="bibr">6</xref>]. As a whole there is also inadequate public education, in tandem with a lack of consistent regulatory systems in place. Both of these, coupled with improper infection control in healthcare, poor sanitation, and water hygiene in low-middle income countries (LMIC), are expanding the AMR challenge [<xref rid="B1-molecules-24-02631" ref-type="bibr">1</xref>,<xref rid="B7-molecules-24-02631" ref-type="bibr">7</xref>].</p><p>Laxminarayan et al. [<xref rid="B7-molecules-24-02631" ref-type="bibr">7</xref>] reported that the antibiotic usage in growth and disease prevention on veterinary, agriculture, aquaculture, and horticulture are the main contributors in the non-clinical setting. In the clinical settings however, lack of antibiotic stewardship and uncertain diagnoses by physicians add to emerging pathogen resistance. In fact, as far back as in 1959, the potentially adverse consequences related to antibiotic misuse resulting in selection pressure to the development of resistance were observed. Recent genetic mutations in pathogens which were aided by chromosomal genes and inter species gene transmission has resulted in the rise of resistant microbes such as methicillin resistant <italic>Staphylococcus aureus</italic> (MRSA), <italic>Escherichia coli</italic> ST131 and <italic>Klebsiella</italic> ST258; this further contributes to the dissemination of resistant genes such as <italic>Klebsiella pneumoniae</italic> carbapenemase (KPC), NDM-1, and Enterobacteriaceae-producing extended-spectrum &#x003b2;-lactamases (ESBL) [<xref rid="B7-molecules-24-02631" ref-type="bibr">7</xref>].</p><p>The continuous dissemination of AMR not only contributes to new resistance mechanisms; it will also have a detrimental impact whereby the efficacy of current antibiotics are drastically reduced, leading to therapeutic failure [<xref rid="B8-molecules-24-02631" ref-type="bibr">8</xref>]. It is worrisome to note that in 2010, there were almost 1000 resistant cases worldwide associated with &#x003b2;-lactamases, a 10-fold increase since 1990 [<xref rid="B9-molecules-24-02631" ref-type="bibr">9</xref>]. Correlation between antibiotic misuse and AMR is clearly evidenced when quinolone misuse caused the revival of MRSA 30 years after it was first introduced in 1962, while carbapenem misconduct via overuse causing resistance in Enterobacteriaceae has significantly increased over the past decade [<xref rid="B7-molecules-24-02631" ref-type="bibr">7</xref>]. In addition, loss of function of ampicillin and gentamicin under the World Health Organisation (WHO) recommended dosage in neonatal infection-related pathogens such as <italic>Klebsiella</italic> spp. and <italic>E. coli</italic> was common in the hospitals of developing countries [<xref rid="B10-molecules-24-02631" ref-type="bibr">10</xref>]. This was attributed to the high mortality rates of sepsis cases caused by carbapenem-resistant <italic>Enterobacteriaceae</italic> and <italic>Acinetobacter</italic> spp. in neonatal nurseries. It was also noted by Saleem [<xref rid="B11-molecules-24-02631" ref-type="bibr">11</xref>] that in Pakistan, common oral antibiotics such as cefixime and ciprofloxacin have become inefficient in Gram-negative pathogens such as <italic>E. coli</italic>, bacteria commonly associated with urinary infection. Barbieri [<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>] stated in his review that dissemination of AMR inadvertently affected health systems in the community in LMICs due to the escalating cost of accessing necessary therapies and the prolonged duration of illness caused by AMR which increases treatment time.</p><p>Bacterial resistance is commonly mediated by transfer of resistance genes [<xref rid="B12-molecules-24-02631" ref-type="bibr">12</xref>]. Overall, there are four main ways in which resistance is acquired, firstly, via inactivation of the drug (<xref ref-type="fig" rid="molecules-24-02631-f001">Figure 1</xref>) as reported by Shen [<xref rid="B13-molecules-24-02631" ref-type="bibr">13</xref>]. The modification of the antibiotics which occurred based on their target location (bacterial cell wall, cytoplasm, and genome) rendered ineffective to that antibiotic [<xref rid="B14-molecules-24-02631" ref-type="bibr">14</xref>]. The second method is the specific modification (<xref ref-type="fig" rid="molecules-24-02631-f001">Figure 1</xref>) at the target such as penicillin-binding protein (PBPs) in MRSA [<xref rid="B15-molecules-24-02631" ref-type="bibr">15</xref>]. Similar modifications may arise from mutational or post-translational modifications [<xref rid="B3-molecules-24-02631" ref-type="bibr">3</xref>]. Furthermore, porin mutation causes reduction in the number of porins, preventing antibiotic entry and thus increased resistance to antibiotics [<xref rid="B16-molecules-24-02631" ref-type="bibr">16</xref>]. Mutations can either be acquired from existing genes (vertical transfer) or new genes can be acquired from other cells (horizontal gene transfer) [<xref rid="B17-molecules-24-02631" ref-type="bibr">17</xref>]. Third is the ability of the bacteria to obtain genes for metabolic pathways, these genes then prevent antimicrobial agents from binding to their target. For instance, mobile genes in resistant <italic>Enterococcus</italic> spp. can be disseminated to susceptible strains via horizontal transfer mediated by conjugative plasmids [<xref rid="B18-molecules-24-02631" ref-type="bibr">18</xref>]. Finally, the fourth method of bacterial resistance is the reduction of antimicrobial agent intracellularly due to the presence of a bacterial efflux pump. In fact, some resistant bacteria increase impermeability in the cell membrane or increase active efflux, both of which result in reduced drug concentration (<xref ref-type="fig" rid="molecules-24-02631-f001">Figure 1</xref>) in the bacterial cell [<xref rid="B19-molecules-24-02631" ref-type="bibr">19</xref>]. The up-regulation in expression of efflux pump has been found to be a major resistance mechanism in many bacteria [<xref rid="B20-molecules-24-02631" ref-type="bibr">20</xref>].</p><p>Strategies to curb the ongoing emergence of AMR require the involvement from various parties. They include policy makers to develop antibiotic regulations, pharmacists and physicians to practice proper antibiotic stewardship, the pharmaceutical industry to invest in new antibiotic discovery, as well as academics to provide adequate public education [<xref rid="B7-molecules-24-02631" ref-type="bibr">7</xref>]. Some strategies for control and containment of AMR included extensive surveillance of antimicrobials, especially for antibiotic prescriptions amongst health care providers, avoiding unnecessary use of antimicrobials in the agricultural sectors, limiting drugs advertising, improvising on sanitation, in tandem with continuous research of novel drugs and invention of nanotechnology; these were some of the measures to be implemented [<xref rid="B7-molecules-24-02631" ref-type="bibr">7</xref>]. A shift in focus towards alternative therapies targeting AMR mechanisms would also be an important aspect and these include incorporation of antimicrobial peptides (AMPs), phage therapy, metalloantibiotics, lipopolysaccharides, efflux pump inhibitors, and phytochemicals [<xref rid="B1-molecules-24-02631" ref-type="bibr">1</xref>].</p><p>Antimicrobial agents may comprise of naturally-occurring compounds such as phytochemicals and essential oils (EOs) [<xref rid="B21-molecules-24-02631" ref-type="bibr">21</xref>]. They can also be either semi-synthetic or synthetic [<xref rid="B22-molecules-24-02631" ref-type="bibr">22</xref>] in nature. Natural secondary metabolites which have a molecular weight &#x02264;500 g/mol may have the ability to act as adjuvants for antimicrobials and exhibit synergy effects [<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>,<xref rid="B23-molecules-24-02631" ref-type="bibr">23</xref>]. Exploration of new antimicrobial agents via biotransformation such as through microbial modification may present an important alternative [<xref rid="B24-molecules-24-02631" ref-type="bibr">24</xref>]. Combination therapy of an antimicrobial agent with a low molecular weight natural product, such as terpene derivatives have shown promising effects, with the ability to eliminate fungal and bacterial biofilm production [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>]. Terpenes and their derivatives are secondary metabolites which are commonly found in EOs and have been shown to have antimicrobial activities against susceptible and resistant pathogens [<xref rid="B25-molecules-24-02631" ref-type="bibr">25</xref>]. Combination therapy between natural compounds and drugs may be able to recover the loss of function for existing antimicrobial agents [<xref rid="B26-molecules-24-02631" ref-type="bibr">26</xref>], potentiating the action of drugs. Wagner and Merzenich [<xref rid="B27-molecules-24-02631" ref-type="bibr">27</xref>] reported that the potentiation of antimicrobial agents was accomplished via several mechanisms in combinatorial therapy; these provide a multi-targeted pharmacokinetic effect, allowing simultaneous destruction of existing resistance mechanisms in a specific pathogen.</p><p>EOs are naturally produced from aromatic plants such as herbs as their secondary metabolites. Usually EOs exist in liquid form, are volatile and exhibit good solubility in lipids and inorganic compounds that are less dense compared to water. They can be extracted from various parts of the plant organ such as flowers, buds, leave, bark, twigs, stem, wood, seed, or root [<xref rid="B28-molecules-24-02631" ref-type="bibr">28</xref>] by various methods which include solvent extraction (solvent, supercritical CO<sub>2</sub>, subcritical water), distillation (steam, hydrodistillation, hydrodiffusion), solvent-free (microwave) and combination method (solvent + steam) [<xref rid="B29-molecules-24-02631" ref-type="bibr">29</xref>]. Generally, plants store their EOs in specific cellular compartments such as in the secretory cells, cavities, or glandular trichomes. EOs primarily function as protection against plant pests and infections [<xref rid="B30-molecules-24-02631" ref-type="bibr">30</xref>]. In particular, EOs have been reported to be a prominent antimicrobial, antioxidant, and insecticidal agent, significantly inhibiting microbial biofilm production and the growth of bacteria, yeasts, and molds [<xref rid="B31-molecules-24-02631" ref-type="bibr">31</xref>]. Previously our group has also focused on the bacterial membranous disruption effect when subjected to treatment with EOs [<xref rid="B32-molecules-24-02631" ref-type="bibr">32</xref>]. A list of reports summarized in <xref rid="molecules-24-02631-t001" ref-type="table">Table 1</xref> indicate various antimicrobial activities possessed by EOs. In 2018, our research group demonstrated synergistic activity when peppermint (<italic>Mentha x piperita</italic> L. Carl) essential oil was added to meropenem against resistant <italic>E. coli</italic> [<xref rid="B33-molecules-24-02631" ref-type="bibr">33</xref>]. Recently, our research group established a mode of action of EO from cinnamon bark against KPC-KP via oxidative stress [<xref rid="B34-molecules-24-02631" ref-type="bibr">34</xref>]. There are challenges involved in working with EOs. They are laborious to handle as they need to be extracted and purified before being tested and manipulated. Furthermore, despite EOs being used for testing, it is difficult to ascertain as to which bioactive component in EOs is contributing to the antimicrobial activity. Acquisition of EOs will also require higher cost as compared to synthetic additives because they need to be processed prior to screening for their activity. One method to resolve the cost issue involves downscaling the volume via extraction of the antimicrobial compounds. This review in particular will focus on one such compound commonly found in EOs, namely the terpenes and their antimicrobial potential and their possible mechanisms of action.</p></sec><sec id="sec2-molecules-24-02631"><title>2. Terpenes and Their Derivatives</title><p>Terpenes are large hydrocarbon groups that consist of 5-carbon isoprene (C5H8) units as their basic building block. They are synthesized via two pathways which are the non-mevalonate pathway; the Methylerythritol Phosphate (MEP) and the mevalonate pathway from Acetyl CoA precursor. Their backbones can be reorganized into cyclic structure by cyclases. The commonly found terpenes which differ in numbers of isoprene units are the monoterpenes and sesquiterpenes; however longer chains such as diterpenes and triterpenes also exist [<xref rid="B47-molecules-24-02631" ref-type="bibr">47</xref>,<xref rid="B54-molecules-24-02631" ref-type="bibr">54</xref>]. P-Cymene, limonene, sabinene, terpinene, carene, and pinene are examples belonging to the terpene groups. Most terpenes possess reduced antimicrobial activities [<xref rid="B54-molecules-24-02631" ref-type="bibr">54</xref>]. Terpenoids are derivatives of terpenes which takes place when modification of terpenes occur, such as with the addition/removal of functional groups [<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>]. Therefore, the antimicrobial activity of terpenoids are determined from their functional group [<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>]. For instance, the shifting or removal of a methyl group and addition of oxygen by a specific enzyme result in derivation of terpenes. The hydroxyl group of the phenolic terpenoids and delocalized electrons are amongst the antimicrobial determining factors. Linalool, menthol, carvacrol, thymol, linalyl acetrate, piperitone, geraniol, and citronella are amongst the best studied terpenoids.</p><sec id="sec2dot1-molecules-24-02631"><title>2.1. Bioactive Terpenes and Terpenoids</title><p>Terpenoids represent a large group of phytochemicals with promising antimicrobial activity [<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>]. The chemical diversity of terpenoids have led to discovery of over 40,000 structural varieties, with a few classes serving as pharmaceutical agents, some of which include terpenoid derived indole alkaloids [<xref rid="B56-molecules-24-02631" ref-type="bibr">56</xref>]. There are a total of eight different classes of terpenoids (hemiterpenoids, monoterpenoids, sesquiterpenoids, diterpenoids, sesterpenoids, triterpenoids, tetrapenoids, and polyterpenoids) which differ in the number of isoprene (C5H8) units. Recently in 2017, it was reported that 67% of potentiators belong to monoterpenes and sesquiterpenes [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>]. Meanwhile, specifically among the discovered potentiators of antibacterial drugs, 75% were terpenes; these include classes of mono-, di-, and tri-terpenes [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>].</p><p>Although the antibacterial mode of action of terpenes remains largely unknown, Griffin et al. [<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>] reported in his study that most terpenoids are able to inhibit two crucial processes which are essential to microbial survival, this includes oxygen uptake and oxidative phosphorylation. Aerobic microbes require oxygen in order to yield energy for their growth. Previously, it was proven that low oxygen concentrations caused limitation in bacterial respiration rates [<xref rid="B57-molecules-24-02631" ref-type="bibr">57</xref>]. Meanwhile, oxidative phosphorylation is a crucial biochemical process responsible for cellular respiration that takes place in the cytoplasmic membrane. Thus, terpene interaction leads to alteration in cellular respiration which later causes uncoupling of oxidative phosphorylation in the microbe [<xref rid="B58-molecules-24-02631" ref-type="bibr">58</xref>]. Additionally, carbonylation of terpenoids was believed to increase bacteriostatic activity but not necessarily the bactericidal activity. A bacteriostatic agent is an agent that stops or inhibits microbial growth, while a bactericidal is responsible for killing the microbe. Terpenoids have also been found to exhibit antiseptic potential according to their solubility in water. Lipophilicity and/or hydrophobicity and presence of hydroxyl groups in the terpenes are amongst the determining elements of their antibacterial action [<xref rid="B58-molecules-24-02631" ref-type="bibr">58</xref>]. In skin barrier-associated treatment, terpenes have also been reported to affect the lipid membrane activity by interacting with lipophilic tails of intermembrane lipid and polar head groups which, at the end, affects the lipodial intermembrane and polar transmembrane pathways [<xref rid="B59-molecules-24-02631" ref-type="bibr">59</xref>].</p><sec id="sec2dot1dot1-molecules-24-02631"><title>2.1.1. Monoterpenes and Monoterpenoids</title><p>Monoterpenes comprise of two isoprene units and exist in many plants. It has been reported by Griffin et al. [<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>] that monotepenes possess antimicrobial activity. For instance, carvacrol, thymol, menthol, and geraniol were able to work against Gram-positive and Gram-negative bacteria. Geraniol was also later claimed to efficiently increase the susceptibility of the Gram-negative multi-drug resistant (MDR) <italic>Enterobacter aerogenes</italic> by becoming a potent efflux pump inhibitor [<xref rid="B60-molecules-24-02631" ref-type="bibr">60</xref>]. Trombetta et al. [<xref rid="B61-molecules-24-02631" ref-type="bibr">61</xref>] claimed in his study that three monoterpenes linalyl acetate, (+) menthol and thymol showed positive responses against <italic>S. aureus</italic> and <italic>E. coli.</italic> Other compounds such as carvacrol, trans-cinnamaldehyde and (+)-carvone were reported to possess potent inhibitory activity against <italic>E. coli</italic> and <italic>S. typhimurium</italic> [<xref rid="B30-molecules-24-02631" ref-type="bibr">30</xref>]. In addition, other types of monoterpenes such as halogenated monoterpenes recorded good cytotoxic, antimalarial, and antialgal effects while monocyclic monoterpenes had been reported to exhibit potent insecticidal, as well as antifungal effects [<xref rid="B62-molecules-24-02631" ref-type="bibr">62</xref>].</p><p>In fact, in as early as 1979, Kurita et al. [<xref rid="B63-molecules-24-02631" ref-type="bibr">63</xref>] had listed a total of 13 monoterpenes ((+)-terpinen-4-ol, &#x003b3;-terpinene, &#x003b1;-terpinene, terpinolene, &#x003b1;-pinene 1,8-cineole, &#x003c1;-cymene, (+)-limonene, &#x003b2;-myrcene, (+)-&#x003b2;-pinene, (&#x000b1;)-linalool, &#x003b1;-phellandrene, &#x003b1;-terpinoel) which exhibited antifungal properties against 14 fungal strains. The phenolic monoterpenes such as carvacrol, eugenol and thymol were found to be highly active against bacteria [<xref rid="B64-molecules-24-02631" ref-type="bibr">64</xref>]. There were twenty one monoterpenes (borneol, d-3-carene, carvacrol, carvacrol methyl ester, <italic>cis/trans</italic> citral, eugenol, geraniol, Geranyl acetate, <italic>cis</italic>-hex-3-en-1-ol, R(+)limonene, (2)-linalool, menthone, nerol, &#x003b1;-pinene, &#x003b2;-pinene, (+)sabinene, &#x003b1;-terpinene, terpinen-4-ol, &#x003b1;-terpineole, (&#x02212;)-thujone, thymol) which were previously reported regarding their antimicrobial activity against 25 bacterial strains [<xref rid="B65-molecules-24-02631" ref-type="bibr">65</xref>]. Phenol monoterpenes, such as carvacrol were also reported to inhibit biofilm development of <italic>S.aureus</italic> and <italic>S. typhimurium</italic> [<xref rid="B66-molecules-24-02631" ref-type="bibr">66</xref>]. Recently, our research group found one monoterpene compound, linalool, extracted from lavender essential oil which exhibited strong antimicrobial activity against resistant <italic>K. pneumoniae</italic> [<xref rid="B34-molecules-24-02631" ref-type="bibr">34</xref>]. The proposed mechanism of action for the compound was membrane disruption [<xref rid="B34-molecules-24-02631" ref-type="bibr">34</xref>].</p><p>Monoterpene ketones were also found to exhibit antimicrobial properties [<xref rid="B67-molecules-24-02631" ref-type="bibr">67</xref>]. In comparison, alcoholic monoterpenes are more bactericidal agents rather than bacteriostatic agents. In line with this, Bhatti et al. [<xref rid="B67-molecules-24-02631" ref-type="bibr">67</xref>] reported that monoterpenes alcohol of terpinen-4-ol, &#x003b1;-terpineol, 1, 8-cineole and linalool exhibited good antifungal activity and suggested alcohol moieties as determinants of antifungal activity. In addition, myrcene, one of the acyclic monoterpene alcohols showed a negative response against fungal specimens; this infers that the cyclic structure of monoterpenes may also be the structure responsible for this activity [<xref rid="B68-molecules-24-02631" ref-type="bibr">68</xref>]. Monoterpenes consisting of aldehydes, however, possessed a potent antimicrobial activity which can be explained through its carbon double bond arrangements; this creates high electronegativity. The observations of nine monoterpenes (&#x003b1;-terpinene, &#x003b3;-terpinene, &#x003b1;-pinene, &#x003c1;-cymene, terpinen-4-ol, &#x003b1;-terpineol, thymol, citral and 1, 8-cineole) against <italic>Herpes simplex virus</italic> type 1 (HSV-1) were made by Thompson in 1989. Later in 2010, Dunkic et al. [<xref rid="B69-molecules-24-02631" ref-type="bibr">69</xref>] listed a few more monoterpenes having considerable activity against HSV-1 which are borneol, bornyl acetate, and isoborneol, 1, 8-cineole, thujone, and camphor. Thymol and carvacrol were also noted to be powerful agents against the <italic>Tobacco mosaic virus</italic> (TMV) and <italic>Cucumber mosaic virus</italic> (CMV) [<xref rid="B70-molecules-24-02631" ref-type="bibr">70</xref>].</p></sec><sec id="sec2dot1dot2-molecules-24-02631"><title>2.1.2. Sesquiterpenes and Sesquiterpenoids</title><p>It has been long recognized that sesquiterpenes possess antimicrobial activites [<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>]. Back in 2011, Torres-Romero et al. [<xref rid="B71-molecules-24-02631" ref-type="bibr">71</xref>] identified one of dihydro-&#x003b2; agarofuran sesquiterpenes, namely 1&#x003b1;-acetoxy-6&#x003b2;, 9&#x003b2;-dibenzoyloxy-dihydro-&#x003b2;-agarofuran inhibits the growth of <italic>Bacillus</italic> spp. [<xref rid="B71-molecules-24-02631" ref-type="bibr">71</xref>]. Farnesol, which is an isoprenoid natural acyclic sesquiterpene alcohol showed moderate effects against <italic>Streptococcus mutans</italic> and <italic>Streptococcus sobrinus</italic> biofilm formation [<xref rid="B72-molecules-24-02631" ref-type="bibr">72</xref>]. Farnesol also showed antibacterial activity against <italic>S. aureus</italic> and <italic>S. epidermidis</italic> whereby it inhibited the biofilm development [<xref rid="B73-molecules-24-02631" ref-type="bibr">73</xref>]. Two studies conducted by Masako [<xref rid="B74-molecules-24-02631" ref-type="bibr">74</xref>] evidenced that combinations of farnesol with xylitol have positive effects against atopic dermatitis caused by <italic>S. aureus</italic> without altering the microbial flora and successfully inhibited the biofilm production of <italic>S. aureus</italic>. Sesquiterpenes were also incorporated in the combination therapy using existing drugs.</p><p>A recent study conducted by Castelo-Branco et al. [<xref rid="B75-molecules-24-02631" ref-type="bibr">75</xref>] showed potentiation effects of a combination therapy of farnesol with amoxicillin, doxycycline, ceftazidime, and sulfamethoxazole-trimethoprim against <italic>B. pseudomallei</italic>. A phenol sesquiterpene, xanthorrhizol was found to reduce 60% of <italic>Staphylococcus mutans</italic> cell adherence ability [<xref rid="B76-molecules-24-02631" ref-type="bibr">76</xref>], and inhibited the growth of <italic>Mycobacterium smegmatis</italic> [<xref rid="B77-molecules-24-02631" ref-type="bibr">77</xref>]. Recently, it was discovered that sesquiterpenes have potent antibiotic enhancement against MRSA and also Gram-negative bacteria [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>]. In 2011, Gon&#x000e7;alves et al. [<xref rid="B78-molecules-24-02631" ref-type="bibr">78</xref>] reported a significantly larger inhibition zone when sesquiterpenes were incorporated into antibiotic discs. The experiment was conducted against MDR strains of <italic>S. aureus</italic> with a combination of sets of available antibiotics such as tetracycline, erythromycin, penicillin, and vancomycin.</p></sec><sec id="sec2dot1dot3-molecules-24-02631"><title>2.1.3. Diterpenes and Diterpenoids</title><p>Diterpene is a class of terpene with broad biological activities [<xref rid="B79-molecules-24-02631" ref-type="bibr">79</xref>]. Previously, 60 terpenoids have been tested for their minimum inhibitory concentration (MIC) against <italic>P. aeruginosa, E. coli, S. aureus,</italic> and <italic>C. albicans</italic> [<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>]. They were then classified into five groups to determine their activity patterns. Hydrogen bond was found to be the factor that determines the positive antimicrobial activity. On the other hand, low water solubility was discovered to be the factor of antimicrobial inactivity. Griffin [<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>] suggested that inhibition of microbial oxygen uptake and oxidative phosphorylation are likely mechanisms of action responsible for the antimicrobial properties of the diterpene class. Separately, diterpene derivatives such as ent-kaurane and ent-pimarane are able to inhibit growth of the dental caries pathogens. The MIC value of 2&#x02013;10 mg/mL confirmed the antibacterial potential of the compounds [<xref rid="B80-molecules-24-02631" ref-type="bibr">80</xref>]. Additionally, the diterpenoid salvipisone prevented cell adherence and biofilm developments of <italic>S. aureus</italic> and <italic>S. epidermidis</italic> [<xref rid="B81-molecules-24-02631" ref-type="bibr">81</xref>].</p><p>Besides sesquiterpenes, diterpenes also function as a good antibiotic enhancer against MRSA. Moreover, diterpenes have been widely used in combination therapy with antibiotics [<xref rid="B82-molecules-24-02631" ref-type="bibr">82</xref>]. For instance, clerodane diterpenoid 16&#x003b1;hydroxycleroda-3, 13 (14)-Z-dien-15, 16-olide (CD) extracted from leaves of <italic>Polyathia longifolia</italic> enhanced the efficacy of oxacillin, tetracycline, daptomycin, and linezolid against clinical isolates of MRSA. All MICs of the antibiotic dropped significantly between 10&#x02013;80, 4&#x02013;16, 2&#x02013;8 and 2&#x02013;4-folds respectively when combined with CD. Gupta et al. [<xref rid="B82-molecules-24-02631" ref-type="bibr">82</xref>] then proposed the in vivo mechanism of CD in reversing the resistance of clinical isolates of MRSA. The same clinical MRSA isolates were tested with CD combined with norfloxacin, ciprofloxacin, and ofloxacin. qRT-PCR analysis showed that the expression of genes coding for efflux pumps were significantly modulated in cells treated with CD alone and in combination with antimicrobial drugs. In fact, the results of time-kill assay showed the MIC in combination of CD with norfloxacin was half of the MIC of CD and norfloxacin alone, undoubtedly decreasing the viability of bacterial cells. Unfortunately, despite the promising effects offered by CD, sourcing to obtain CD became the bottleneck for further testing [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>].</p><p>Salvipisone and aethiopinone are diterpenoids isolated from roots of <italic>Salvia sclarea</italic> [<xref rid="B81-molecules-24-02631" ref-type="bibr">81</xref>]. They were shown to express antibacterial and antibiofilm activities against <italic>S. aureus, Enterococcus faecalis</italic> and <italic>S. epidermidis.</italic> Both salvipisone and aethiopinone were also tested for their synergistic activity when combined with antimicrobial drugs alongside oxacillin, vancomycin, and linezolid against MRSA and Methicillin resistant <italic>Staphylococcus epidermidis</italic> (MRSE). It was discovered that they were either bactericidal or bacteriostatic against planktonic cultures of tested MRSA and MRSE [<xref rid="B83-molecules-24-02631" ref-type="bibr">83</xref>]. Remarkably, the MIC was achieved with 50% reduction in the dose of antibiotic when diterpenoids were used in combination.</p></sec><sec id="sec2dot1dot4-molecules-24-02631"><title>2.1.4. Triterpenes and Triterpenoids</title><p>Triterpenes comprises of six isoprene units. It was reported that <italic>Pandanaceae</italic> containing triterpenes in the form of 24, 24-dimethyl-5&#x003b2;-tirucall-9 [<xref rid="B11-molecules-24-02631" ref-type="bibr">11</xref>], 25-dien-3-one showed promising activities against tubercular strains. Another triterpene, Oleanic acid (OA) is potent against pathogens such as <italic>Mycobacterium tuberculosis.</italic> OA also had promising synergy against MDR when combined with rifampicin, isoniazide, and ethambutol with significant MIC reduction of 128&#x02013;16 fold, 32&#x02013;4 fold, and from 128 to 16 fold, respectively [<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>].</p><p>Besides OA, bonianic acid A and B are two triterpenoids that were extracted from <italic>Radermachera boniana.</italic> Both compounds were found to be active against <italic>M. tuberculosis</italic>. There are at least six known molecules which include OA, ergosterol peroxide, and ursolic acid (UA). In fact, the combination of both ergosterol peroxide and UA showed synergistic activity against <italic>M. tuberculosis</italic> [<xref rid="B84-molecules-24-02631" ref-type="bibr">84</xref>]. The reports conducted by Cunha et al. [<xref rid="B85-molecules-24-02631" ref-type="bibr">85</xref>] depicted that OA and UA that were isolated from <italic>Miconia ligustroides</italic>, resulted in significant antibacterial activity when tested on selected bacteria (<italic>B. cereus, Vibrio cholerae, S. choleraesuis, K. pneumoniae and S. pneumoniae</italic>). When UA was used against <italic>B. cereus,</italic> the MIC value was 20 &#x000b5;g/mL and OA showed MIC value of 80 &#x000b5;g/mL against <italic>B. cereus</italic> and <italic>S. pneumoniae</italic>. In 2013, a study conducted by Zhou et al. [<xref rid="B86-molecules-24-02631" ref-type="bibr">86</xref>] showed that UA and OA were active against planktonic cariogenic microorganism and their biofilm. Later in 2015, Liu et al. [<xref rid="B31-molecules-24-02631" ref-type="bibr">31</xref>] expanded the research and reported the combinatory effects of UA and xylitol against biofilm produced by <italic>S. mutans and S. sobrinus</italic>. Moreover, OA and UA were reported to enhance antimicrobial activity against <italic>Listeria monocytogenes</italic> without affecting toxin secretion; this influenced the virulence factors of <italic>L. monocytogenes</italic> and inhibited the capacity of biofilm production from these bacteria [<xref rid="B45-molecules-24-02631" ref-type="bibr">45</xref>].</p><p>OA also exhibited strong interactions alongside aminoglycoside (gentamicin and kanamycin) against <italic>A. baumanii</italic>, but not with other classes of which ampicillin, norfloxacin, chloramphenicol, tetracycline, and rifampicin are examples [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>]. Based on time-kill assay, the bactericidal effects of gentamicin were significantly greater when combined with OA compared to gentamicin alone [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>]. Three triterpenoids, amyrin, betulinic acid, and betulinaldehyde were extracted from the bark of <italic>Callicarpa farinose</italic> Roxb (Verbenaceae) and were shown to exhibit potent antimicrobial activity against clinical methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) with MICs ranging from 2 to 512 &#x000b5;g/mL [<xref rid="B87-molecules-24-02631" ref-type="bibr">87</xref>].</p><p>While there is no firm report specifically on modes of action by terpenoids, the mechanisms of action of phytochemicals found in nature have been proposed. Typically, phytochemicals aim either for disruption of the bacterial cell membranes, modulation of bacterial efflux pump, suppression of bacterial biofilm development or inhibition of some virulence factors which include enzymes and toxins [<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>]. For instance, carvacrol was found to be responsible for sub-lethal injury to bacterial cells due to alteration of fatty acid compositions, while other reports state that carvacrol and thymol caused disintegration of the outer membrane and disruption of the cytoplasmic membrane of Gram-negative bacteria [<xref rid="B30-molecules-24-02631" ref-type="bibr">30</xref>]. Antimicrobial activity effects of some terpenoids are summarized in <xref rid="molecules-24-02631-t002" ref-type="table">Table 2</xref> while the postulated mode of action of terpenes on antibiotic resistance pathogens and as combination therapies are depicted in <xref ref-type="fig" rid="molecules-24-02631-f002">Figure 2</xref>.</p></sec></sec><sec id="sec2dot2-molecules-24-02631"><title>2.2. Therapeutic Implementation</title><sec id="sec2dot2dot1-molecules-24-02631"><title>2.2.1. Drugs and Antibiotics</title><p>Combination therapy with terpenes have been widely seen in current therapeutic practice especially in antifungal drugs [<xref rid="B26-molecules-24-02631" ref-type="bibr">26</xref>]. It was shown that fluconazole which had once lost its efficacy, had been potentiated by monoterpenes, thymol, and carvacrol when subjected against 38 fluconazole-sensitive <italic>C. albicans, C. tropicalis</italic>, and <italic>C. glabrata</italic> and 11 fluconazole-resistant <italic>C. albicans, C. krusei, C. glabrata, C. tropicalis,</italic> and <italic>C. parapsilopsis</italic>. The combination analysis showed that of the strains tested, 32 out of 38 strains and eight out of 10 strains have obtained a Fractional Inhibitory Concentration (FIC) index of less than 0.5 [<xref rid="B88-molecules-24-02631" ref-type="bibr">88</xref>]. FIC is a term used to express the degree of synergy interaction between antibacterial drugs whereby FIC &#x0003c; 0.5 shows positive synergism while FIC &#x0003e; 0.5 shows negative synergism [<xref rid="B89-molecules-24-02631" ref-type="bibr">89</xref>]. The sequiterpene, farnesol, also showed potentiation activity with fluconazole against candidiasis [<xref rid="B88-molecules-24-02631" ref-type="bibr">88</xref>]. Previously, it was reported that three diterpene compounds, ent-clerodanes (bacchotricuneatin, bacrispine and hawtriwaic acid) which were isolated from <italic>Baccharis</italic> extract synergistically reduced the dose of the anti-fungal drug Terbinafine against <italic>Trichophyton rubrum</italic> [<xref rid="B90-molecules-24-02631" ref-type="bibr">90</xref>]. Another triterpene, retigeric acid, found in the lichenized fungi family, Lobariaceae exhibited strong potentiation when combined with either fluconazole, itraconazole or ketoconazole against azole-resistant <italic>C. albicans</italic> strains [<xref rid="B91-molecules-24-02631" ref-type="bibr">91</xref>]. It was proposed that facilitation of azole uptake or membranous repair associated with azoles were the modes of action of retigeric acid.</p><p>Prior to the development of novel drugs, in vitro and in vivo testing are usually performed to ascertain the safety and efficacy of the compound to better understand the physiological effects. Despite a number of published in vitro reports pertaining to terpenes antimicrobial testing, incorporation of various terpenes in clinical trials focusing on antimicrobial activity is still lacking due to insufficient data on the in vivo system. Most in vivo testing for terpenes and its derivatives has been conducted for human health associated with anti-inflammatory, anti-tumorigenic, anti-cancer, transdermal delivery medium and neuroprotective [<xref rid="B92-molecules-24-02631" ref-type="bibr">92</xref>] aspects. However, incorporation of terpenes into household products and cosmetics due to antibacterial properties showed increasing assurance in vivo, inhibiting multiple species of bacteria [<xref rid="B93-molecules-24-02631" ref-type="bibr">93</xref>]. In 2006, Mondello et al. [<xref rid="B94-molecules-24-02631" ref-type="bibr">94</xref>] demonstrated in vivo activity of the monoterpene terpinen-4-ol which is the main bioactive constituent of <italic>Malaleuca alternifolia</italic> Cheel (tea tree) oil against azole-susceptible and resistant human pathogenic candida species. In this demonstration, terpinen-4-ol was able to clear a well-established model of rat vaginal candidiasis. Terpenes which were found in <italic>Cassia occidentalis</italic> and <italic>Phyllanthus niruri</italic> showed antimalarial activity in vivo using mice against <italic>Plasmodium berghei</italic> [<xref rid="B95-molecules-24-02631" ref-type="bibr">95</xref>]. In addition, &#x003b2;-sitosterol was tested in the treatment of culture proven pulmonary tuberculosis (PTB) patients using blinded randomized placebo-controlled trials. Two groups of patients consisting of a sitosterol group and a placebo group were set up upon the treatment. Patients were hospitalized for the duration of treatment and checked monthly with regards to sputum culture positivity, chest radiography, weight gain, hematology, liver function, and Mantoux test response. At the end of trials, it was reported that the sitosterol group marked a greater weight gain, lymphocyte and eosinophils count compared to the other group [<xref rid="B96-molecules-24-02631" ref-type="bibr">96</xref>].</p></sec><sec id="sec2dot2dot2-molecules-24-02631"><title>2.2.2. Terpenes Bioavailability</title><p>In order to ensure greater therapeutic effect from drugs, terpene bioavailability should be determined. It was reported that while natural volatile terpenes from 1,8-cineole of uncrushed capsule from the plasma yielded relatively 100% of bioavailability, limomene and &#x003b1;-pinene were only detectable for a few subjects [<xref rid="B97-molecules-24-02631" ref-type="bibr">97</xref>]. In 2017, research conducted by Papada et al. [<xref rid="B98-molecules-24-02631" ref-type="bibr">98</xref>] demonstrated positive bioavailability of major terpenes from Mastiha powder after 30 min of ingestion with the highest peak between 2&#x02013;4 h post ingestion. The plasma analysis was done using ultra-high-pressure liquid chromatography high-resolution MS (UHPLC-HRMS/MS). The bioavailability bottleneck of medicinal herbs including terpenes, however, had been improved ever since phytosome technology arrival. It was reported that the bioavailability of <italic>Ginkgo biloba</italic> extract (GBE) which constitutes of the terpene, lactone, was improved significantly with 2&#x02013;4 times greater plasma concentration compared to a non-phytosome delivery method [<xref rid="B99-molecules-24-02631" ref-type="bibr">99</xref>].</p></sec><sec id="sec2dot2dot3-molecules-24-02631"><title>2.2.3. Evaluation of Compounds Interaction in Combination Therapies</title><p>Combination therapies using natural products such as the terpenoids may synergistically, additively, or antagonistically affect the treatments. Zacchino et al. [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>] reported in a review that the nature of interaction between phytochemical and antimicrobial drugs can be determined using the median-effect method of Chou [<xref rid="B89-molecules-24-02631" ref-type="bibr">89</xref>] which permits the calculation of combination index (CI). As for combination therapy, both agents at a fixed ratio will result in IC<sub>50</sub> respectively; these are mixed with two-fold dilutions of both agents with a fixed ratio. The CI will resolve synergistic (CI &#x0003c; 1), additive (CI = 1) and antagonistic effects (CI &#x0003e; 1). In addition, another method that contributed significantly in synergistic activity was to calculate the Dose Reduction Index (DRI), also known as the reversal enhancement ratio, that measures how many folds the dose of antimicrobial drugs may be cut down when used in combination rather than alone. One of the measures that can be used to evaluate synergism is through checkerboard assay.</p><p>In our previous study, through this method, peppermint essential oil was proven to synergistically react with meropenem. MIC of individual peppermint oil and meropenem were 8% and 4 &#x000b5;g/mL respectively. Meanwhile when used in combination, the MIC of peppermint oil and meropenem were reduced to 1% and 0.5 &#x000b5;g/mL respectively. The CI value of 0.26 obtained in checkerboard assay had portrayed a high synergism. Last year, our group carried out extensive analysis to investigate the additive interaction of cinnamon bark oil and meropenem. The shift of attention towards synergism between compounds and antibiotics have caused researchers to overlook the additive effects, thus we conducted the study to understand additive interaction which focused on the effect on the bacterial membrane [<xref rid="B100-molecules-24-02631" ref-type="bibr">100</xref>].</p></sec><sec id="sec2dot2dot4-molecules-24-02631"><title>2.2.4. Methods for Antimicrobial Evaluation</title><p>Both in vitro and in vivo experimental systems can be used to evaluate the antimicrobial activity of either synthetic compounds or naturally-acquired compounds. Nevertheless, in vitro approaches have been more commonly used due to their feasibility. In vivo studies, however, are seldom applied due to limitations in detecting the actual mechanism of action. Susceptibility testing which determines the MIC of a compound against bacteria is routinely done using variations in the methods of MIC assay such as rapid <italic>p</italic>-Iodonitrotetrazolium chloride (INT) colorimetric assay, micro- or macro-dilution and disc diffusion methods. However, Griffin et al. [<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>] stated in his study that the disc diffusion method is prone to problems as the method was highly dependent on water solubility and suitability of the test agent to be diffused through the agar. In combination therapy, however, the effects are assessed through the checkerboard assay which investigated the interaction between agents. The checkerboard antibiofilm microsomal triglyceride transfer protein (MTP) assay through which the checkerboard microdilution was seeded with biofilm have also been used in an experiment associated with biofilm producing bacteria [<xref rid="B88-molecules-24-02631" ref-type="bibr">88</xref>]. By performing the checkerboard assay, an important index called the FIC will reveal the potential of an individual compound [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>]. The Dose Reduction Index (DRI) [<xref rid="B89-molecules-24-02631" ref-type="bibr">89</xref>] can also be conducted in a compound combination analysis in order to find out the dosage reductions ruled out by individual compounds that affected the MIC of the second compound. A greater DRI disclosed better adjuvant capabilities for a given effect level [<xref rid="B89-molecules-24-02631" ref-type="bibr">89</xref>]. More extensively, further analysis usually includes isobolograms and time-kill studies.</p></sec></sec></sec><sec id="sec3-molecules-24-02631"><title>3. Perspectives</title><sec id="sec3dot1-molecules-24-02631"><title>3.1. Ongoing Research</title><p>Effective management and treatment of microbial resistance are among the main priorities in healthcare. Terpene derivatives are an important and promising source of novel antibiotics. Indeed, ent-kaurenoids (ent-kaur-15-en-18, 20-diol and ent-kaur-15-en-18-ol) extracted from <italic>Senegalia nigrescens</italic> are among the novel terpene derivatives discovered recently. Both in vitro and in silico anti-quorum sensing evaluation have demonstrated potential anti-quorum sensing against <italic>Chromobacterium violaceum</italic> [<xref rid="B101-molecules-24-02631" ref-type="bibr">101</xref>]. In addition, it was reported that antiquorum sensing does not contribute towards evolution of MDR pathogens as there is no enforcement of selection pressure [<xref rid="B32-molecules-24-02631" ref-type="bibr">32</xref>]. Additionally, terpenoids found in microbial volatile compounds (MVCs) have exhibited the ability to combat and modulate antibiotic resistance in human and animal pathogens [<xref rid="B102-molecules-24-02631" ref-type="bibr">102</xref>].</p><p>With the success of terpenoids in the treatment of microbial resistance, the hunt for new terpenoids has been an important quest amongst the scientific community as a potential application. For instance, screening for terpenoids was conducted on semi-arid plants such as <italic>Caesalpinia pulcherrima, Lawsonia inermis, Pithecellobium dulce, Euphorbia tithymaloides, Punica granatum, Plumeria obtusa, Carica papaya, Cassia fistula, Cordia dichotoma, Euphorbia prostrate, Nerium oleander</italic>, and <italic>Cyanthillium cinereum</italic> [<xref rid="B103-molecules-24-02631" ref-type="bibr">103</xref>]. A separate study conducted in 2018 identified three terpenoid derivatives (&#x003b1;-pinene&#x02014;45.44%, 3-carene&#x02014;38.34%, and terpinolene&#x02014;5.36%) of <italic>Cupressus torulosa</italic> essential oil. The compounds are effective against pathogens including <italic>B.subtilis, Pseudomonas alcaligenes, M. luteus,</italic> and <italic>B. cereus</italic> [<xref rid="B104-molecules-24-02631" ref-type="bibr">104</xref>]. This can mitigate AMR problems by manipulating combinatory therapeutics of existing antimicrobial agents with terpenoid derivatives. <italic>Ganoderma lucidum</italic> (Reishi) which is a medicinal mushroom, contains several triterpenoid substances such as ganoderic acid and lucidenic acid. The compounds were then evaluated for their therapeutic effects whereby they exhibited anti-human immunodeficiency virus (HIV) activity by inhibiting the effects of HIV progression [<xref rid="B105-molecules-24-02631" ref-type="bibr">105</xref>].</p></sec><sec id="sec3dot2-molecules-24-02631"><title>3.2. Application of Terpenoids in Clinical Settings: Challenges</title><p>As mentioned previously, terpenes and terpenoids had been known to exert antimicrobial activity against a wide variety of bacteria, both Gram-positive and Gram-negative. Clinical trials regarding highlighting the application of terpenes had been performed in several studies. In addition, &#x003b2;-sitosterol had also demonstrated immune enhancing ability in tuberculosis patients, demonstrating significant weight gain and higher white blood cell counts which resulted in faster recovery [<xref rid="B106-molecules-24-02631" ref-type="bibr">106</xref>]. However, the application of terpenes as antimicrobials in the clinical phase is yet to be explored. This can be attributed to several factors, as the mode of actions of terpenes is not fully understood and the amount of time and resources required for clinical trials are limited and not always rewarding [<xref rid="B107-molecules-24-02631" ref-type="bibr">107</xref>]. Terpenes consist of a diverse group of lipophilic organic compounds, resulting in different structures which affect their mode of action. &#x003b2;-caryophyllene showed poor antimicrobial activity against a panel of bacteria [<xref rid="B108-molecules-24-02631" ref-type="bibr">108</xref>]. In the event whereby terpenes with efficient antimicrobial activities have been discovered, the safety of the terpenes would often be the next obstacle prior to clinical trials. Certain terpenes are reported to be toxic at low dosage and thus not preferred [<xref rid="B109-molecules-24-02631" ref-type="bibr">109</xref>]. For instance, even at 1% dose of eugenol, it was reported to effectively inhibit growth of <italic>Dermanyssus gallinae</italic> at 20% of the pathogen population. Eugenol, geraniol, and citral found in plant essential oils were able to administer 100% mortality when used undiluted. This shows that some undiluted terpenes are highly toxic upon direct usage [<xref rid="B110-molecules-24-02631" ref-type="bibr">110</xref>]. Generally, the unfavorable toxicity of terpenes towards whole cells takes place due to disturbance; primarily disrupting cell membrane integrity which eventually leads to cell lysis [<xref rid="B111-molecules-24-02631" ref-type="bibr">111</xref>]. Due to the lipophilic nature of terpenes, upon ingestion, they are easily absorbed by epidermal cells before reaching the site of infection. Thus, delicate drug delivery systems are required for their application into clinical trials.</p></sec><sec id="sec3dot3-molecules-24-02631"><title>3.3. Future Prospects</title><p>The evidenced antimicrobial activity of terpenes and their derivatives need to be further expounded with the aid of automation and advancement in technology. Experimental analyses will need to be more streamlined to become more precise, resulting in less ambiguity so that the results obtained can be ensured and are consistent. This will reduce the time taken for experimental work and more time can be spent for extended analyses. Researchers may then study the modification effects of natural products with a special focus on terpenoids. Structural modifications of natural compounds produced either synthetically or via biotransformation may offer a new facet in finding novel AMR solutions as it explores new antimicrobial agents. In addition, delivery methods involving existing treatments against AMR should be improved and new inventions can be investigated. Combination therapeutics may be enhanced by exploring more antimicrobial adjuvants which will synergistically affect treatment outcomes with greater efficiency and less side effects. Natural terpenes and terpenoids which are available at very low prices such as carvacrol, thymol, and geraniol [<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>], should be optimally used for development of good antibacterial combination drugs. However, application at the pharmaceutical level remains challenging as the in vivo after effect is, currently, still very much unexplored. Extended analysis involving well-designed clinical trials should be improved in order to manipulate potent compounds of terpenoids to the best of their functional potential.</p></sec></sec><sec sec-type="conclusions" id="sec4-molecules-24-02631"><title>4. Conclusions</title><p>From this review, it has been evidenced that some terpenes and their derivatives were proven to be potent antimicrobial agents against drug resistant pathogens which mainly include bacteria and fungi. Specific mechanisms of each class of terpenes have also been highlighted and as a whole, terpenes provide a possible mitigation route for AMR and navigating the dead end of the diminishing antibiotic pipeline, hence, an appropriate match between terpenoids and existing antimicrobial agents may provide ultimate therapeutic options for AMR-associated infections.</p></sec></body><back><ack><title>Acknowledgments</title><p>Special thanks are given to the HCT Research Grant for financial support of the research.</p></ack><notes><title>Author Contributions</title><p>Authors would also like to thank all the members of Floral Biotechnology Laboratory, UPM. K.-S.L. designed the manuscript. N.A.M. drafted the manuscript. S.-H.E.L. significantly refined the manuscript whereas K.-S.L., S.-K.Y., C.-L.M., A.A.-L.S., C.-M.C. and C.-W.C. edited the draft. All authors read and approved the final manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by the HCT Research Grant (113123) from the Higher Colleges of Technology, UAE.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>All authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-24-02631"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>S.M.</given-names></name><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Ghosh</surname><given-names>A.K.</given-names></name><name><surname>Hazra</surname><given-names>T.K.</given-names></name><name><surname>Basak</surname><given-names>A.</given-names></name><name><surname>Franco</surname><given-names>O.L.</given-names></name></person-group><article-title>Challenges and future prospects of antibiotic therapy: From peptides to phages utilization</article-title><source>Front. Pharmacol.</source><year>2014</year><volume>5</volume><fpage>105</fpage><pub-id pub-id-type="doi">10.3389/fphar.2014.00105</pub-id><?supplied-pmid 24860506?><pub-id pub-id-type="pmid">24860506</pub-id></element-citation></ref><ref id="B2-molecules-24-02631"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbieri</surname><given-names>R.</given-names></name><name><surname>Coppo</surname><given-names>E.</given-names></name><name><surname>Marchese</surname><given-names>A.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name><name><surname>Sobarzo-S&#x000e1;nchez</surname><given-names>E.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name></person-group><article-title>Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity</article-title><source>Microbiol. Res.</source><year>2017</year><volume>196</volume><fpage>44</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2016.12.003</pub-id><?supplied-pmid 28164790?><pub-id pub-id-type="pmid">28164790</pub-id></element-citation></ref><ref id="B3-molecules-24-02631"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>J.M.</given-names></name><name><surname>Webber</surname><given-names>M.A.</given-names></name><name><surname>Baylay</surname><given-names>A.J.</given-names></name><name><surname>Ogbolu</surname><given-names>D.O.</given-names></name><name><surname>Piddock</surname><given-names>L.J.</given-names></name></person-group><article-title>Molecular mechanisms of antibiotic resistance</article-title><source>Nat. Rev. Microbiol.</source><year>2015</year><volume>1</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.1038/nrmicro3380</pub-id><?supplied-pmid 25435309?><pub-id pub-id-type="pmid">25435309</pub-id></element-citation></ref><ref id="B4-molecules-24-02631"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacchino</surname><given-names>S.A.</given-names></name><name><surname>Butassi</surname><given-names>E.</given-names></name><name><surname>Cordisco</surname><given-names>E.</given-names></name><name><surname>Svetaz</surname><given-names>L.A.</given-names></name></person-group><article-title>Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms</article-title><source>Phytomedicine</source><year>2017</year><volume>37</volume><fpage>14</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2017.10.021</pub-id><?supplied-pmid 29174600?><pub-id pub-id-type="pmid">29174600</pub-id></element-citation></ref><ref id="B5-molecules-24-02631"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajagopal</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>M.J.</given-names></name><name><surname>Santiago</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>W.</given-names></name><name><surname>Kos</surname><given-names>V.N.</given-names></name><name><surname>Meredith</surname><given-names>T.</given-names></name><name><surname>Gilmore</surname><given-names>M.S.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name></person-group><article-title>Multidrug intrinsic resistance factors in <italic>Staphylococcus aureus</italic> identified by profiling fitness within high-diversity transposon libraries</article-title><source>MBio</source><year>2016</year><volume>7</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1128/mBio.00950-16</pub-id></element-citation></ref><ref id="B6-molecules-24-02631"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K.</given-names></name></person-group><article-title>Persister cells, dormancy and infectious disease</article-title><source>Nat. Rev. Microbiol.</source><year>2007</year><volume>5</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1557</pub-id><pub-id pub-id-type="pmid">17143318</pub-id></element-citation></ref><ref id="B7-molecules-24-02631"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laxminarayan</surname><given-names>R.</given-names></name><name><surname>Duse</surname><given-names>A.</given-names></name><name><surname>Wattal</surname><given-names>C.</given-names></name><name><surname>Zaidi</surname><given-names>A.K.M.</given-names></name><name><surname>Wertheim</surname><given-names>H.F.L.</given-names></name><name><surname>Sumpradit</surname><given-names>N.</given-names></name><name><surname>Vlieghe</surname><given-names>E.</given-names></name><name><surname>Hara</surname><given-names>G.L.</given-names></name><name><surname>Gould</surname><given-names>I.M.</given-names></name><name><surname>Goossens</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Antibiotic resistance-the need for global solutions</article-title><source>Lancet Infect. Dis.</source><year>2013</year><volume>13</volume><fpage>1057</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70318-9</pub-id><pub-id pub-id-type="pmid">24252483</pub-id></element-citation></ref><ref id="B8-molecules-24-02631"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Touani</surname><given-names>F.K.</given-names></name><name><surname>Seukep</surname><given-names>A.J.</given-names></name><name><surname>Djeussi</surname><given-names>D.E.</given-names></name><name><surname>Fankam</surname><given-names>A.G.</given-names></name><name><surname>Noumedem</surname><given-names>J.A.K.</given-names></name><name><surname>Kuete</surname><given-names>V.</given-names></name></person-group><article-title>Antibiotic-potentiation activities of four Cameroonian dietary plants against multidrug-resistant Gram-negative bacteria expressing efflux pumps</article-title><source>BMC Complement. Altern. Med.</source><year>2014</year><volume>1</volume><elocation-id>258</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-14-258</pub-id></element-citation></ref><ref id="B9-molecules-24-02631"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>J.</given-names></name><name><surname>Davies</surname><given-names>D.</given-names></name></person-group><article-title>Origins and Evolution of Antibiotic Resistance</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2010</year><volume>3</volume><fpage>417</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00016-10</pub-id></element-citation></ref><ref id="B10-molecules-24-02631"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaidi</surname><given-names>A.K.M.</given-names></name><name><surname>Huskins</surname><given-names>W.C.</given-names></name><name><surname>Thaver</surname><given-names>D.</given-names></name><name><surname>Bhutta</surname><given-names>Z.A.</given-names></name><name><surname>Abbas</surname><given-names>Z.</given-names></name><name><surname>Goldmann</surname><given-names>D.A.</given-names></name></person-group><article-title>Hospital-acquired neonatal infections in developing countries</article-title><source>Lancet</source><year>2005</year><volume>365</volume><fpage>1175</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(05)71881-X</pub-id><pub-id pub-id-type="pmid">15794973</pub-id></element-citation></ref><ref id="B11-molecules-24-02631"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleem</surname><given-names>A.F.</given-names></name><name><surname>Ahmed</surname><given-names>I.</given-names></name><name><surname>Mir</surname><given-names>F.</given-names></name><name><surname>Ali</surname><given-names>S.R.</given-names></name><name><surname>Zaidi</surname><given-names>A.K.M.</given-names></name></person-group><article-title>Pan-resistant Acinetobacter infection in neonates in Karachi, Pakistan</article-title><source>J. Infect. Dev. Ctries.</source><year>2010</year><volume>4</volume><fpage>30</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.3855/jidc.533</pub-id></element-citation></ref><ref id="B12-molecules-24-02631"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>K.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name><name><surname>Dantas</surname><given-names>G.</given-names></name><name><surname>Davies</surname><given-names>J.</given-names></name><name><surname>Eisenstein</surname><given-names>B.</given-names></name><name><surname>Huovinen</surname><given-names>P.</given-names></name><name><surname>Jacoby</surname><given-names>G.A.</given-names></name><name><surname>Kishony</surname><given-names>R.</given-names></name><name><surname>Kreiswirth</surname><given-names>B.N.</given-names></name><name><surname>Kutter</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Tackling antibiotic resistance</article-title><source>Nat. Rev. Microbiol.</source><year>2011</year><volume>9</volume><fpage>894</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2693</pub-id><pub-id pub-id-type="pmid">22048738</pub-id></element-citation></ref><ref id="B13-molecules-24-02631"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Davis</surname><given-names>L.E.</given-names></name><name><surname>Wallace</surname><given-names>J.M.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Lawson</surname><given-names>L.D.</given-names></name></person-group><article-title>Enhanced diallyl trisulfide has in vitro synergy with amphotericin B against <italic>Cryptococcus neoformans</italic></article-title><source>Planta Med.</source><year>1996</year><volume>62</volume><fpage>415</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1055/s-2006-957929</pub-id><pub-id pub-id-type="pmid">8923805</pub-id></element-citation></ref><ref id="B14-molecules-24-02631"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.K.</given-names></name><name><surname>Low</surname><given-names>L.Y.</given-names></name><name><surname>Yap</surname><given-names>P.S.X.</given-names></name><name><surname>Yusoff</surname><given-names>K.</given-names></name><name><surname>Mai</surname><given-names>C.W.</given-names></name><name><surname>Lai</surname><given-names>K.S.</given-names></name><name><surname>Lim</surname><given-names>S.H.</given-names></name></person-group><article-title>Plant-derived antimicrobials: Insights into mitigation of antimicrobial resistance</article-title><source>Rec. Nat. Prod.</source><year>2018</year><volume>12</volume><fpage>295</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.25135/rnp.41.17.09.058</pub-id></element-citation></ref><ref id="B15-molecules-24-02631"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spratt</surname><given-names>B.G.</given-names></name></person-group><article-title>Resistance to antibiotics mediated by target alterations</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>388</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1126/science.8153626</pub-id><pub-id pub-id-type="pmid">8153626</pub-id></element-citation></ref><ref id="B16-molecules-24-02631"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baroud</surname><given-names>M.</given-names></name><name><surname>Dandache</surname><given-names>I.</given-names></name><name><surname>Araj</surname><given-names>G.F.</given-names></name><name><surname>Wakim</surname><given-names>R.</given-names></name><name><surname>Kanj</surname><given-names>S.</given-names></name><name><surname>Kanafani</surname><given-names>Z.</given-names></name><name><surname>Khairallah</surname><given-names>M.</given-names></name><name><surname>Sabra</surname><given-names>A.</given-names></name><name><surname>Shehab</surname><given-names>M.</given-names></name><name><surname>Dbaibo</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Underlying mechanisms of carbapenem resistance in extended-spectrum &#x003b2;-lactamase-producing <italic>Klebsiella pneumoniae</italic> and <italic>Escherichia coli</italic> isolates at a tertiary care centre in Lebanon: Role of OXA-48 and NDM-1 carbapenemases</article-title><source>Int. J. Antimicrob. Agents</source><year>2013</year><volume>41</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2012.08.010</pub-id><pub-id pub-id-type="pmid">23142087</pub-id></element-citation></ref><ref id="B17-molecules-24-02631"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmieder</surname><given-names>R.</given-names></name><name><surname>Edwards</surname><given-names>R.</given-names></name></person-group><article-title>Insights into antibiotic resistance through metagenomic approaches</article-title><source>Future Microbiol.</source><year>2012</year><volume>7</volume><fpage>73</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.2217/fmb.11.135</pub-id><pub-id pub-id-type="pmid">22191448</pub-id></element-citation></ref><ref id="B18-molecules-24-02631"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>K.L.</given-names></name><name><surname>Kos</surname><given-names>V.N.</given-names></name><name><surname>Gilmore</surname><given-names>M.S.</given-names></name></person-group><article-title>Horizontal gene transfer and the genomics of enterococcal antibiotic resistance</article-title><source>Curr. Opin. Microbiol.</source><year>2010</year><volume>13</volume><fpage>632</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2010.08.004</pub-id><pub-id pub-id-type="pmid">20837397</pub-id></element-citation></ref><ref id="B19-molecules-24-02631"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikaido</surname><given-names>H.</given-names></name></person-group><article-title>Prevention of drug access to bacterial targets: Permeability barriers and active efflux</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>382</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1126/science.8153625</pub-id><pub-id pub-id-type="pmid">8153625</pub-id></element-citation></ref><ref id="B20-molecules-24-02631"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>R.E.W.</given-names></name></person-group><article-title>Mechanisms of action of newer antibiotics for Gram-positive pathogens</article-title><source>Lancet Infect. Dis.</source><year>2005</year><volume>5</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70051-7</pub-id><pub-id pub-id-type="pmid">15792738</pub-id></element-citation></ref><ref id="B21-molecules-24-02631"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moo</surname><given-names>C.L.</given-names></name><name><surname>Yang</surname><given-names>S.K.</given-names></name><name><surname>Yusoff</surname><given-names>K.</given-names></name><name><surname>Ajat</surname><given-names>M.</given-names></name><name><surname>Thomas</surname><given-names>W.</given-names></name><name><surname>Abushelaibi</surname><given-names>A.</given-names></name><name><surname>Lim</surname><given-names>S.H.</given-names></name><name><surname>Lai</surname><given-names>K.S.</given-names></name></person-group><article-title>Mechanisms of antimicrobial resistance (AMR) and alternative approaches to overcome AMR</article-title><source>Curr. Drug Discov. Technol.</source><year>2019</year><volume>16</volume><pub-id pub-id-type="doi">10.2174/1570163816666190304122219</pub-id></element-citation></ref><ref id="B22-molecules-24-02631"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudramurthy</surname><given-names>G.R.</given-names></name><name><surname>Swamy</surname><given-names>M.K.</given-names></name><name><surname>Sinniah</surname><given-names>U.R.</given-names></name><name><surname>Ghasemzadeh</surname><given-names>A.</given-names></name></person-group><article-title>Nanoparticles: Alternatives against drug-resistant pathogenic microbes</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>836</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21070836</pub-id></element-citation></ref><ref id="B23-molecules-24-02631"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langeveld</surname><given-names>W.T.</given-names></name><name><surname>Veldhuizen</surname><given-names>E.J.A.</given-names></name><name><surname>Burt</surname><given-names>S.A.</given-names></name></person-group><article-title>Synergy between essential oil components and antibiotics: A review</article-title><source>Crit. Rev. Microbiol.</source><year>2014</year><volume>40</volume><fpage>76</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.3109/1040841X.2013.763219</pub-id><pub-id pub-id-type="pmid">23445470</pub-id></element-citation></ref><ref id="B24-molecules-24-02631"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Qin</surname><given-names>L.</given-names></name></person-group><article-title>Recent developments and future prospects of antimicrobial metabolites produced by endophytes</article-title><source>Microbiol. Res.</source><year>2010</year><volume>165</volume><fpage>437</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2009.11.009</pub-id><pub-id pub-id-type="pmid">20116229</pub-id></element-citation></ref><ref id="B25-molecules-24-02631"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thapa</surname><given-names>D.</given-names></name><name><surname>Louis</surname><given-names>P.</given-names></name><name><surname>Losa</surname><given-names>R.</given-names></name><name><surname>Zweifel</surname><given-names>B.</given-names></name><name><surname>Wallace</surname><given-names>R.J.</given-names></name></person-group><article-title>Essential oils have different effects on human pathogenic and commensal bacteria in mixed faecal fermentations compared with pure cultures</article-title><source>Microbiology</source><year>2015</year><volume>161</volume><fpage>441</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000009</pub-id><pub-id pub-id-type="pmid">25500493</pub-id></element-citation></ref><ref id="B26-molecules-24-02631"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>R.E.</given-names></name><name><surname>Kontoyiannis</surname><given-names>D.P.</given-names></name></person-group><article-title>Rationale for combination antifungal therapy</article-title><source>Pharmacotherapy</source><year>2001</year><volume>21</volume><fpage>149S</fpage><lpage>164S</lpage><pub-id pub-id-type="doi">10.1592/phco.21.12.149S.34505</pub-id><pub-id pub-id-type="pmid">11501988</pub-id></element-citation></ref><ref id="B27-molecules-24-02631"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Ulrich-Merzenich</surname><given-names>G.</given-names></name></person-group><article-title>Synergy research: Approaching a new generation of phytopharmaceuticals</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>97</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2008.12.018</pub-id><pub-id pub-id-type="pmid">19211237</pub-id></element-citation></ref><ref id="B28-molecules-24-02631"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oussalah</surname><given-names>M.</given-names></name><name><surname>Caillet</surname><given-names>S.</given-names></name><name><surname>Saucier</surname><given-names>L.</given-names></name><name><surname>Lacroix</surname><given-names>M.</given-names></name></person-group><article-title>Inhibitory effects of selected plant essential oils on the growth of four pathogenic bacteria: <italic>E. coli</italic> O157:H7, <italic>Salmonella Typhimurium, Staphylococcus aureus</italic> and <italic>Listeria monocytogenes</italic></article-title><source>Food Control</source><year>2007</year><volume>18</volume><fpage>414</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2005.11.009</pub-id></element-citation></ref><ref id="B29-molecules-24-02631"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tongnuanchan</surname><given-names>P.</given-names></name><name><surname>Benjakul</surname><given-names>S.</given-names></name></person-group><article-title>Essential oils: Extraction, bioactivities, and their uses for food preservation</article-title><source>J. Food Sci.</source><year>2014</year><volume>7</volume><pub-id pub-id-type="doi">10.1111/1750-3841.12492</pub-id></element-citation></ref><ref id="B30-molecules-24-02631"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helander</surname><given-names>I.M.</given-names></name><name><surname>Alakomi</surname><given-names>H.L.</given-names></name><name><surname>Latva-Kala</surname><given-names>K.</given-names></name><name><surname>Mattila-Sandholm</surname><given-names>T.</given-names></name><name><surname>Pol</surname><given-names>I.</given-names></name><name><surname>Smid</surname><given-names>E.J.</given-names></name><name><surname>Gorris</surname><given-names>L.G.</given-names></name><name><surname>Wright</surname><given-names>A.</given-names></name></person-group><article-title>Characterization of the action of selected essential oil components on Gram-negative bacteria</article-title><source>Agric. Food Chem.</source><year>1998</year><volume>46</volume><fpage>590</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1021/jf980154m</pub-id></element-citation></ref><ref id="B31-molecules-24-02631"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Niu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Mu</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Duan</surname><given-names>J.</given-names></name></person-group><article-title>Synergy among thymol, eugenol, berberine, cinnamaldehyde and streptomycin against planktonic and biofilm-associated food-borne pathogens</article-title><source>Lett. Appl. Microbiol.</source><year>2015</year><volume>60</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1111/lam.12401</pub-id></element-citation></ref><ref id="B32-molecules-24-02631"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>P.S.X.</given-names></name><name><surname>Yang</surname><given-names>S.K.</given-names></name><name><surname>Lai</surname><given-names>K.S.</given-names></name><name><surname>Lim</surname><given-names>S.H.</given-names></name></person-group><article-title>Essential oils: The ultimate solution to antimicrobial resistance in <italic>Escherichia coli</italic>?</article-title><source>Escherichia coli-Recent Advances on Physiology, Pathogenesis and Biotechnological Applications</source><person-group person-group-type="editor"><name><surname>Samie</surname><given-names>A.</given-names></name></person-group><publisher-name>Intech Open</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2017</year><fpage>299</fpage><lpage>313</lpage></element-citation></ref><ref id="B33-molecules-24-02631"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.K.</given-names></name><name><surname>Yap</surname><given-names>P.S.X.</given-names></name><name><surname>Krishnan</surname><given-names>T.</given-names></name><name><surname>Yusoff</surname><given-names>K.</given-names></name><name><surname>Chan</surname><given-names>K.G.</given-names></name><name><surname>Yap</surname><given-names>W.S.</given-names></name><name><surname>Lai</surname><given-names>K.S.</given-names></name><name><surname>. Lim</surname><given-names>S.H.</given-names></name></person-group><article-title>Mode of action: Synergistic interaction of peppermint (<italic>Mentha x piperita</italic> L. Carl) essential oil and meropenem against plasmid-mediated resistant <italic>E. coli</italic></article-title><source>Rec. Nat. Prod.</source><year>2018</year><volume>12</volume><fpage>582</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.25135/rnp.59.17.12.078</pub-id></element-citation></ref><ref id="B34-molecules-24-02631"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.K.</given-names></name><name><surname>Yusoff</surname><given-names>K.</given-names></name><name><surname>Ajat</surname><given-names>M.</given-names></name><name><surname>Thomas</surname><given-names>W.</given-names></name><name><surname>Abushelaibi</surname><given-names>A.</given-names></name><name><surname>Akseer</surname><given-names>R.</given-names></name><name><surname>Lim</surname><given-names>S.E.</given-names></name><name><surname>Lai</surname><given-names>K.S.</given-names></name></person-group><article-title>Disruption of KPC-producing <italic>Klebsiella pneumoniae</italic> membrane via induction of oxidative stress by cinnamon bark (<italic>Cinnamomum verum</italic> J. Presl) essential oil</article-title><source>PLoS ONE</source><year>2019</year><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0214326</pub-id></element-citation></ref><ref id="B35-molecules-24-02631"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maida</surname><given-names>I.</given-names></name><name><surname>Lo Nostro</surname><given-names>A.</given-names></name><name><surname>Pesavento</surname><given-names>G.</given-names></name><name><surname>Barnabei</surname><given-names>M.</given-names></name><name><surname>Calonico</surname><given-names>C.</given-names></name><name><surname>Perrin</surname><given-names>E.</given-names></name><name><surname>Chiellini</surname><given-names>C.</given-names></name><name><surname>Fondi</surname><given-names>M.</given-names></name><name><surname>Mengoni</surname><given-names>A.</given-names></name><name><surname>Maggini</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Exploring the anti- <italic>Burkholderia cepacia</italic> complex activity of essential oils: A preliminary analysis</article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2014</year><volume>2014</volume><pub-id pub-id-type="doi">10.1155/2014/573518</pub-id></element-citation></ref><ref id="B36-molecules-24-02631"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasooli</surname><given-names>I.</given-names></name><name><surname>Shayegh</surname><given-names>S.</given-names></name><name><surname>Astaneh</surname><given-names>S.D.A.</given-names></name></person-group><article-title>The effect of <italic>Mentha spicata</italic> and <italic>Eucalyptus camaldulensis</italic> essential oils on dental biofilm</article-title><source>Int. J. Dent. Hyg.</source><year>2009</year><volume>7</volume><fpage>196</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1111/j.1601-5037.2009.00389.x</pub-id><pub-id pub-id-type="pmid">19659716</pub-id></element-citation></ref><ref id="B37-molecules-24-02631"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Rajendran</surname><given-names>S.</given-names></name><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Kundu</surname><given-names>B.</given-names></name></person-group><article-title>Antifungal activities of selected essential oils against <italic>Fusarium oxysporum</italic> f. sp. lycopersici 1322, with emphasis on <italic>Syzygium aromaticum</italic> essential oil</article-title><source>J. Biosci. Bioeng.</source><year>2017</year><volume>123</volume><fpage>308</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.jbiosc.2016.09.011</pub-id><pub-id pub-id-type="pmid">27876218</pub-id></element-citation></ref><ref id="B38-molecules-24-02631"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrigod</surname><given-names>N.M.</given-names></name><name><surname>Swami Hulle</surname><given-names>N.R.</given-names></name><name><surname>Prasad</surname><given-names>R.V.</given-names></name></person-group><article-title>Supercritical fluid extraction of essential oil from mint leaves (<italic>Mentha spicata</italic>): Process optimization and its quality evaluation</article-title><source>J. Food Process Eng.</source><year>2017</year><volume>40</volume><fpage>12488</fpage><pub-id pub-id-type="doi">10.1111/jfpe.12488</pub-id></element-citation></ref><ref id="B39-molecules-24-02631"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adukwu</surname><given-names>E.C.</given-names></name><name><surname>Bowles</surname><given-names>M.</given-names></name><name><surname>Edwards-Jones</surname><given-names>V.</given-names></name><name><surname>Bone</surname><given-names>H.</given-names></name></person-group><article-title>Antimicrobial activity, cytotoxicity and chemical analysis of lemongrass essential oil (<italic>Cymbopogon flexuosus</italic>) and pure citral</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2016</year><volume>100</volume><fpage>9619</fpage><lpage>9627</lpage><pub-id pub-id-type="doi">10.1007/s00253-016-7807-y</pub-id><pub-id pub-id-type="pmid">27562470</pub-id></element-citation></ref><ref id="B40-molecules-24-02631"><label>40.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>De Andrade</surname><given-names>F.B.</given-names></name><name><surname>Midena</surname><given-names>R.Z.</given-names></name><name><surname>Koga-Ito</surname><given-names>C.Y.</given-names></name><name><surname>Duarte</surname><given-names>M.A.</given-names></name></person-group><article-title>Conventional and natural products against oral infections. Microbial pathogens and strategies for combating them: Science, technology and education</article-title><source>Pathogens and Strategies for Combating Them: Science, Technology and Education</source><person-group person-group-type="editor"><name><surname>M&#x000e9;ndez-Vilas</surname><given-names>A.</given-names></name></person-group><publisher-name>FORMATEX Research Center</publisher-name><publisher-loc>Badajoz, Spain</publisher-loc><year>2013</year><fpage>1574</fpage><lpage>1583</lpage></element-citation></ref><ref id="B41-molecules-24-02631"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasireddy</surname><given-names>L.</given-names></name><name><surname>Bingle</surname><given-names>L.E.H.</given-names></name><name><surname>Davies</surname><given-names>M.S.</given-names></name></person-group><article-title>Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the <italic>Burkholderia cepacia</italic> complex</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><pub-id pub-id-type="doi">10.1371/journal.pone.0201835</pub-id></element-citation></ref><ref id="B42-molecules-24-02631"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grzesiak</surname><given-names>B.</given-names></name><name><surname>G&#x00142;owacka</surname><given-names>A.</given-names></name><name><surname>Krukowski</surname><given-names>H.</given-names></name><name><surname>Lisowski</surname><given-names>A.</given-names></name><name><surname>Lassa</surname><given-names>H.</given-names></name><name><surname>Sienkiewicz</surname><given-names>M.</given-names></name></person-group><article-title>The in vitro efficacy of essential oils and antifungal drugs against <italic>Prototheca zopfii</italic></article-title><source>Mycopathologia</source><year>2016</year><volume>181</volume><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1007/s11046-016-9994-6</pub-id><pub-id pub-id-type="pmid">26940809</pub-id></element-citation></ref><ref id="B43-molecules-24-02631"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafiq</surname><given-names>R.</given-names></name><name><surname>Hayek</surname><given-names>S.</given-names></name><name><surname>Anyanwu</surname><given-names>U.</given-names></name><name><surname>Hardy</surname><given-names>B.</given-names></name><name><surname>Giddings</surname><given-names>V.</given-names></name><name><surname>Ibrahim</surname><given-names>S.</given-names></name><name><surname>Tahergorabi</surname><given-names>R.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name></person-group><article-title>Antibacterial and antioxidant activities of essential oils from <italic>Artemisia herba-alba</italic> Asso., <italic>Pelargonium capitatum</italic> radens and <italic>Laurus nobilis</italic> L.</article-title><source>Foods</source><year>2016</year><volume>5</volume><elocation-id>28</elocation-id><pub-id pub-id-type="doi">10.3390/foods5020028</pub-id></element-citation></ref><ref id="B44-molecules-24-02631"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peixoto</surname><given-names>L.R.</given-names></name><name><surname>Rosalen</surname><given-names>P.L.</given-names></name><name><surname>Ferreira</surname><given-names>G.L.S.</given-names></name><name><surname>Freires</surname><given-names>I.A.</given-names></name><name><surname>de Carvalho</surname><given-names>F.G.</given-names></name><name><surname>Castellano</surname><given-names>L.R.</given-names></name><name><surname>Castro</surname><given-names>R.D.</given-names></name></person-group><article-title>Antifungal activity, mode of action and anti-biofilm effects of <italic>Laurus nobilis Linnaeus</italic> essential oil against <italic>Candida</italic> spp.</article-title><source>Arch. Oral Biol.</source><year>2017</year><volume>73</volume><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2016.10.013</pub-id><pub-id pub-id-type="pmid">27771586</pub-id></element-citation></ref><ref id="B45-molecules-24-02631"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurekci</surname><given-names>C.</given-names></name><name><surname>Padmanabha</surname><given-names>J.</given-names></name><name><surname>Bishop-Hurley</surname><given-names>S.L.</given-names></name><name><surname>Hassan</surname><given-names>E.</given-names></name><name><surname>Al Jassim</surname><given-names>R.A.M.</given-names></name><name><surname>McSweeney</surname><given-names>C.S.</given-names></name></person-group><article-title>Antimicrobial activity of essential oils and five terpenoid compounds against <italic>Campylobacter jejuni</italic> in pure and mixed culture experiments</article-title><source>Int. J. Food Microbiol.</source><year>2013</year><volume>166</volume><fpage>450</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2013.08.014</pub-id><pub-id pub-id-type="pmid">24041998</pub-id></element-citation></ref><ref id="B46-molecules-24-02631"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rapper</surname><given-names>S.</given-names></name><name><surname>Viljoen</surname><given-names>A.</given-names></name><name><surname>Van Vuuren</surname><given-names>S.</given-names></name></person-group><article-title>The in vitro antimicrobial effects of <italic>Lavandula angustifolia</italic> essential oil in combination with conventional antimicrobial agents</article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/2752739</pub-id></element-citation></ref><ref id="B47-molecules-24-02631"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swamy</surname><given-names>M.K.</given-names></name><name><surname>Akhtar</surname><given-names>M.S.</given-names></name><name><surname>Sinniah</surname><given-names>U.R.</given-names></name></person-group><article-title>Antimicrobial properties of plant essential oils against human pathogens and their mode of action: An updated review</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/3012462</pub-id></element-citation></ref><ref id="B48-molecules-24-02631"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Snafi</surname><given-names>A.E.</given-names></name></person-group><article-title>Medical importance of <italic>Anthemis nobilis</italic>&#x02014;A review</article-title><source>As. J. Pharm. Sci. Technol.</source><year>2016</year><volume>6</volume><fpage>89</fpage><lpage>95</lpage></element-citation></ref><ref id="B49-molecules-24-02631"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajlaoui</surname><given-names>H.</given-names></name><name><surname>Mighri</surname><given-names>H.</given-names></name><name><surname>Aouni</surname><given-names>M.</given-names></name><name><surname>Gharsallah</surname><given-names>N.</given-names></name><name><surname>Kadri</surname><given-names>A.</given-names></name></person-group><article-title>Chemical composition and in vitro evaluation of antioxidant, antimicrobial, cytotoxicity and anti-acetylcholinesterase properties of Tunisian <italic>Origanum majorana</italic> L. essential oil</article-title><source>Microb. Pathog.</source><year>2016</year><volume>95</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2016.03.003</pub-id><pub-id pub-id-type="pmid">26997648</pub-id></element-citation></ref><ref id="B50-molecules-24-02631"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garzoli</surname><given-names>S.</given-names></name><name><surname>Bo&#x0017e;ovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Baldisserotto</surname><given-names>A.</given-names></name><name><surname>Sabatino</surname><given-names>M.</given-names></name><name><surname>Cesa</surname><given-names>S.</given-names></name><name><surname>Pepi</surname><given-names>F.</given-names></name><name><surname>Vicentini</surname><given-names>C.B.</given-names></name><name><surname>Manfredini</surname><given-names>S.</given-names></name><name><surname>Ragno</surname><given-names>R.</given-names></name></person-group><article-title>Essential oil extraction, chemical analysis and anti-Candida activity of <italic>Foeniculum vulgare</italic> Miller&#x02013;new approaches</article-title><source>Nat. Prod. Res.</source><year>2018</year><volume>32</volume><fpage>1254</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1080/14786419.2017.1340291</pub-id><pub-id pub-id-type="pmid">28617136</pub-id></element-citation></ref><ref id="B51-molecules-24-02631"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ka&#x0010d;&#x000e1;niov&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Terentjeva</surname><given-names>M.</given-names></name><name><surname>Vukovic</surname><given-names>N.</given-names></name><name><surname>Puchalski</surname><given-names>C.</given-names></name><name><surname>Roychoudhury</surname><given-names>S.</given-names></name><name><surname>Kunov&#x000e1;</surname><given-names>S.</given-names></name><name><surname>Kl&#x0016b;ga</surname><given-names>A.</given-names></name><name><surname>Tok&#x000e1;r</surname><given-names>M.</given-names></name><name><surname>Kluz</surname><given-names>M.</given-names></name><name><surname>Ivani&#x00161;ov&#x000e1;</surname><given-names>E.</given-names></name></person-group><article-title>The antioxidant and antimicrobial activity of essential oils against Pseudomonas spp. isolated from fish</article-title><source>Saudi Pharm. J.</source><year>2017</year><volume>25</volume><fpage>1108</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2017.07.005</pub-id><pub-id pub-id-type="pmid">30166897</pub-id></element-citation></ref><ref id="B52-molecules-24-02631"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zrira</surname><given-names>S.</given-names></name><name><surname>Ghanmi</surname><given-names>M.</given-names></name></person-group><article-title>Chemical composition and antibacterial activity of the essential of <italic>Cedrus atlantica</italic> (Cedarwood oil)</article-title><source>J. Essent. Oil-Bearing Plants.</source><year>2016</year><volume>19</volume><fpage>1267</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2015.1137499</pub-id></element-citation></ref><ref id="B53-molecules-24-02631"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Omari</surname><given-names>K.</given-names></name><name><surname>Hamze</surname><given-names>M.</given-names></name><name><surname>Alwan</surname><given-names>S.</given-names></name><name><surname>Jama</surname><given-names>C.</given-names></name><name><surname>Chihib</surname><given-names>N.E.</given-names></name></person-group><article-title>Antifungal activity of the essential oil of <italic>Micromeria barbata</italic> an endemic lebanese micromeria species collected at North Lebanon</article-title><source>J. Mater. Environ. Sci.</source><year>2016</year><volume>7</volume><fpage>4158</fpage><lpage>4167</lpage></element-citation></ref><ref id="B54-molecules-24-02631"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazzaro</surname><given-names>F.</given-names></name><name><surname>Fratianni</surname><given-names>F.</given-names></name><name><surname>De Martino</surname><given-names>L.</given-names></name><name><surname>Coppola</surname><given-names>R.</given-names></name><name><surname>De Feo</surname><given-names>V.</given-names></name></person-group><article-title>Effect of essential oils on pathogenic bacteria</article-title><source>Pharmaceuticals</source><year>2013</year><volume>6</volume><fpage>1451</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.3390/ph6121451</pub-id><pub-id pub-id-type="pmid">24287491</pub-id></element-citation></ref><ref id="B55-molecules-24-02631"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>S.G.</given-names></name><name><surname>Wyllie</surname><given-names>S.G.</given-names></name><name><surname>Markham</surname><given-names>J.L.</given-names></name><name><surname>Leach</surname><given-names>D.N.</given-names></name></person-group><article-title>The role of structure and molecular properties of terpenoids in determining their antimicrobial activity</article-title><source>Flavour Fragr. J.</source><year>1999</year><volume>14</volume><fpage>322</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1026(199909/10)14:5&#x0003c;322::AID-FFJ837&#x0003e;3.0.CO;2-4</pub-id></element-citation></ref><ref id="B56-molecules-24-02631"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>S.C.</given-names></name></person-group><article-title>Production and engineering of terpenoids in plant cell culture</article-title><source>Nat. Chem. Biol.</source><year>2007</year><volume>3</volume><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2007.8</pub-id><pub-id pub-id-type="pmid">17576426</pub-id></element-citation></ref><ref id="B57-molecules-24-02631"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>M.K.</given-names></name><name><surname>Ingraham</surname><given-names>J.L.</given-names></name></person-group><article-title>Synthesis of macromolecules by <italic>Escherichia coli</italic> near the minimal temperature for growth</article-title><source>J. Bacteriol.</source><year>1967</year><volume>1</volume><fpage>157</fpage><lpage>164</lpage></element-citation></ref><ref id="B58-molecules-24-02631"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zengin</surname><given-names>H.</given-names></name><name><surname>Baysal</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial and antioxidant activity of essential oil terpenes against pathogenic and spoilage-forming bacteria and cell structure-activity relationships evaluated by SEM microscopy</article-title><source>Molecules</source><year>2014</year><volume>11</volume><fpage>17773</fpage><lpage>17798</lpage><pub-id pub-id-type="doi">10.3390/molecules191117773</pub-id></element-citation></ref><ref id="B59-molecules-24-02631"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>Q.D.</given-names></name><name><surname>Chai</surname><given-names>Y.P.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>X.X.</given-names></name></person-group><article-title>Natural terpenes as penetration enhancers for transdermal drug delivery</article-title><source>Molecules</source><year>2016</year><volume>12</volume><elocation-id>1709</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21121709</pub-id></element-citation></ref><ref id="B60-molecules-24-02631"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzi</surname><given-names>V.</given-names></name><name><surname>Muselli</surname><given-names>A.</given-names></name><name><surname>Bernardini</surname><given-names>A.F.</given-names></name><name><surname>Berti</surname><given-names>L.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>J.M.</given-names></name><name><surname>Amaral</surname><given-names>L.</given-names></name><name><surname>Bolla</surname><given-names>J.L.</given-names></name></person-group><article-title>Geraniol restores antibiotic activities against multidrug-resistant isolates from Gram-negative species</article-title><source>Antimicrob. Agents Chemother.</source><year>2009</year><volume>53</volume><fpage>2209</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1128/AAC.00919-08</pub-id><pub-id pub-id-type="pmid">19258278</pub-id></element-citation></ref><ref id="B61-molecules-24-02631"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trombetta</surname><given-names>D.</given-names></name><name><surname>Castelli</surname><given-names>F.</given-names></name><name><surname>Sarpietro</surname><given-names>M.G.</given-names></name><name><surname>Venuti</surname><given-names>V.</given-names></name><name><surname>Cristani</surname><given-names>M.</given-names></name><name><surname>Daniele</surname><given-names>C.</given-names></name><name><surname>Saija</surname><given-names>A.</given-names></name><name><surname>Mazzanti</surname><given-names>G.</given-names></name><name><surname>Bisignano</surname><given-names>G.</given-names></name></person-group><article-title>Mechanisms of antibacterial action of three monoterpenes</article-title><source>Antimicrob. Agents Chemother.</source><year>2005</year><volume>49</volume><fpage>2474</fpage><lpage>2478</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.6.2474-2478.2005</pub-id><pub-id pub-id-type="pmid">15917549</pub-id></element-citation></ref><ref id="B62-molecules-24-02631"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De In&#x000e9;s</surname><given-names>C.</given-names></name><name><surname>Argando&#x000f1;a</surname><given-names>V.H.</given-names></name><name><surname>Rovirosa</surname><given-names>J.</given-names></name><name><surname>San-Mart&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>D&#x000ed;az-Marrero</surname><given-names>A.R.</given-names></name><name><surname>Cueto</surname><given-names>M.</given-names></name><name><surname>Gonz&#x000e1;lez-Coloma</surname><given-names>A.</given-names></name></person-group><article-title>Cytotoxic activity of halogenated monoterpenes from <italic>Plocamium cartilagineum</italic></article-title><source>Zeitschrift fur Naturforsch-Sect. C J. Biosci.</source><year>2004</year><volume>59</volume><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1515/znc-2004-5-609</pub-id></element-citation></ref><ref id="B63-molecules-24-02631"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurita</surname><given-names>N.</given-names></name><name><surname>Miyaji</surname><given-names>M.</given-names></name><name><surname>Kuraney</surname><given-names>R.</given-names></name><name><surname>Takahara</surname><given-names>Y.</given-names></name><name><surname>Ichimura</surname><given-names>K.</given-names></name></person-group><article-title>Antifungal activity and molecular orbital energies of aldehyde compounds from oils of higher plants</article-title><source>Agric. Biol. Chem.</source><year>1979</year><volume>43</volume><fpage>2365</fpage><lpage>2371</lpage></element-citation></ref><ref id="B64-molecules-24-02631"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorman</surname><given-names>H.J.D.</given-names></name><name><surname>Deans</surname><given-names>S.G.</given-names></name></person-group><article-title>Antimicrobial agents from plants: Antibacterial activity of plant volatile oils</article-title><source>J. Appl. Microbiol.</source><year>2000</year><volume>88</volume><fpage>308</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2000.00969.x</pub-id><pub-id pub-id-type="pmid">10736000</pub-id></element-citation></ref><ref id="B65-molecules-24-02631"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>M.</given-names></name><name><surname>Lv</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name></person-group><article-title>Antimicrobial activity of an endophytic Xylaria sp. YX-28 and identification of its antimicrobial compound 7-amino-4-methylcoumarin</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2008</year><volume>78</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1007/s00253-007-1305-1</pub-id><pub-id pub-id-type="pmid">18092158</pub-id></element-citation></ref><ref id="B66-molecules-24-02631"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowles</surname><given-names>J.R.</given-names></name><name><surname>Roller</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>D.B.</given-names></name><name><surname>Naidu</surname><given-names>A.S.</given-names></name></person-group><article-title>Antimicrobial action of carvacrol at different stages of dual-species biofilm development by <italic>Staphylococcus aureus</italic> and <italic>Salmonella enterica</italic> serovar typhimurium</article-title><source>Appl. Environ. Microbiol.</source><year>2005</year><volume>71</volume><fpage>797</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.2.797-803.2005</pub-id><pub-id pub-id-type="pmid">15691933</pub-id></element-citation></ref><ref id="B67-molecules-24-02631"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatti</surname><given-names>H.N.</given-names></name><name><surname>Khan</surname><given-names>S.S.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Rani</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>V.U.</given-names></name><name><surname>Choudhary</surname><given-names>M.I.</given-names></name></person-group><article-title>Biotransformation of monoterpenoids and their antimicrobial activities</article-title><source>Phytomedicine.</source><year>2014</year><volume>21</volume><fpage>1597</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2014.05.011</pub-id><pub-id pub-id-type="pmid">25442268</pub-id></element-citation></ref><ref id="B68-molecules-24-02631"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smid</surname><given-names>E.J.</given-names></name><name><surname>de Witte</surname><given-names>Y.</given-names></name><name><surname>Gorris</surname><given-names>L.G.M.</given-names></name></person-group><article-title>Secondary plant metabolites as control agents of postharvest Penicillium rot on tulip bulbs</article-title><source>Postharvest Biol. Technol.</source><year>1995</year><volume>6</volume><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/0925-5214(95)00010-4</pub-id></element-citation></ref><ref id="B69-molecules-24-02631"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunkic</surname><given-names>V.</given-names></name><name><surname>Bezic</surname><given-names>N.</given-names></name><name><surname>Vuko</surname><given-names>E.</given-names></name><name><surname>Cukrov</surname><given-names>D.</given-names></name></person-group><article-title>Antiphytoviral activity of <italic>Satureja montana</italic> L. ssp. variegata (host) P. W. Ball essential oil and phenol compounds on CMV and TMV</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>6713</fpage><lpage>6721</lpage><pub-id pub-id-type="doi">10.3390/molecules15106713</pub-id></element-citation></ref><ref id="B70-molecules-24-02631"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astani</surname><given-names>A.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Schnitzler</surname><given-names>P.</given-names></name></person-group><article-title>Comparative study on the antiviral activity of selected monoterpenes derived from essential oils</article-title><source>Phytother. Res.</source><year>2010</year><volume>24</volume><fpage>673</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1002/ptr.2955</pub-id><pub-id pub-id-type="pmid">19653195</pub-id></element-citation></ref><ref id="B71-molecules-24-02631"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Romero</surname><given-names>D.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>I.A.</given-names></name><name><surname>Rojas</surname><given-names>R.</given-names></name><name><surname>Gilman</surname><given-names>R.H.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>M.</given-names></name><name><surname>Bazzocchi</surname><given-names>I.L.</given-names></name></person-group><article-title>Dihydro-&#x003b2;-agarofuran sesquiterpenes isolated from <italic>Celastrus vulcanicola</italic> as potential anti-<italic>Mycobacterium tuberculosis</italic> multidrug-resistant agents</article-title><source>Bioorganic Med. Chem.</source><year>2011</year><volume>19</volume><fpage>2182</fpage><lpage>2189</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2011.02.034</pub-id></element-citation></ref><ref id="B72-molecules-24-02631"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>H.</given-names></name><name><surname>Pearson</surname><given-names>S.K.</given-names></name><name><surname>Scott-Anne</surname><given-names>K.</given-names></name><name><surname>Abranches</surname><given-names>J.</given-names></name><name><surname>Cury</surname><given-names>J.A.</given-names></name><name><surname>Rosalen</surname><given-names>P.L.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Marquis</surname><given-names>R.E.</given-names></name><name><surname>Bowen</surname><given-names>W.H.</given-names></name></person-group><article-title>Effects of apigenin and tt-farnesol on glucosyltransferase activity, biofilm viability and caries development in rats</article-title><source>Oral Microbiol. Immunol.</source><year>2002</year><volume>17</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1034/j.1399-302X.2002.170602.x</pub-id><pub-id pub-id-type="pmid">12485324</pub-id></element-citation></ref><ref id="B73-molecules-24-02631"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>F.I.A.</given-names></name><name><surname>Teixeira</surname><given-names>P.</given-names></name><name><surname>Azeredo</surname><given-names>J.</given-names></name><name><surname>Oliveira</surname><given-names>R.</given-names></name></person-group><article-title>Effect of farnesol on planktonic and biofilm cells of <italic>Staphylococcus epidermidis</italic></article-title><source>Curr. Microbiol.</source><year>2009</year><volume>59</volume><fpage>118</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1007/s00284-009-9408-9</pub-id><pub-id pub-id-type="pmid">19365686</pub-id></element-citation></ref><ref id="B74-molecules-24-02631"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masako</surname><given-names>K.</given-names></name><name><surname>Yusuke</surname><given-names>K.</given-names></name><name><surname>Hideyuki</surname><given-names>I.</given-names></name><name><surname>Atsuko</surname><given-names>M.</given-names></name><name><surname>Yoshiki</surname><given-names>M.</given-names></name><name><surname>Kayoko</surname><given-names>M.</given-names></name><name><surname>Makoto</surname><given-names>K.</given-names></name></person-group><article-title>Corrigendum to &#x0201c;A novel method to control the balance of skin microflora. Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin&#x0201d;</article-title><source>J. Dermatol. Sci.</source><year>2005</year><volume>39</volume><fpage>197</fpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2005.08.003</pub-id></element-citation></ref><ref id="B75-molecules-24-02631"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castelo-Branco</surname><given-names>D.S.C.M.</given-names></name><name><surname>Riello</surname><given-names>G.B.</given-names></name><name><surname>Vasconcelos</surname><given-names>D.C.</given-names></name><name><surname>Guedes</surname><given-names>G.M.M.</given-names></name><name><surname>Serpa</surname><given-names>R.</given-names></name><name><surname>Bandeira</surname><given-names>T.J.P.G.</given-names></name><name><surname>Monteiro</surname><given-names>A.J.</given-names></name><name><surname>Cordeiro</surname><given-names>R.A.</given-names></name><name><surname>Rocha</surname><given-names>M.F.</given-names></name><name><surname>Sidrim</surname><given-names>J.J.</given-names></name><etal/></person-group><article-title>Farnesol increases the susceptibility of <italic>Burkholderia pseudomallei</italic> biofilm to antimicrobials used to treat melioidosis</article-title><source>J. Appl. Microbiol.</source><year>2016</year><volume>120</volume><fpage>600</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1111/jam.13027</pub-id><pub-id pub-id-type="pmid">26669506</pub-id></element-citation></ref><ref id="B76-molecules-24-02631"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rukayadi</surname><given-names>Y.</given-names></name><name><surname>Hwang</surname><given-names>J.K.</given-names></name></person-group><article-title>Effect of coating the wells of a polystyrene microtiter plate with xanthorrhizol on the biofilm formation of <italic>Streptococcus mutans</italic></article-title><source>J. Basic Microbiol.</source><year>2006</year><volume>46</volume><fpage>410</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1002/jobm.200510088</pub-id><pub-id pub-id-type="pmid">17009296</pub-id></element-citation></ref><ref id="B77-molecules-24-02631"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name></person-group><article-title>The synergy of honokiol and fluconazole against clinical isolates of azole-resistant <italic>Candida albicans</italic></article-title><source>Lett. Appl. Microbiol.</source><year>2010</year><volume>51</volume><fpage>351</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2010.02900.x</pub-id><pub-id pub-id-type="pmid">20681969</pub-id></element-citation></ref><ref id="B78-molecules-24-02631"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>O.</given-names></name><name><surname>Pereira</surname><given-names>R.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>F.</given-names></name><name><surname>Mendo</surname><given-names>S.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Rocha</surname><given-names>S.M.</given-names></name></person-group><article-title>Evaluation of the mutagenicity of sesquiterpenic compounds and their influence on the susceptibility towards antibiotics of two clinically relevant bacterial strains</article-title><source>Mutat. Res. -Genet. Toxicol. Environ. Mutagen.</source><year>2011</year><volume>723</volume><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.mrgentox.2011.03.010</pub-id></element-citation></ref><ref id="B79-molecules-24-02631"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosio</surname><given-names>S.R.</given-names></name><name><surname>Tirapelli</surname><given-names>C.R.</given-names></name><name><surname>da Costa</surname><given-names>F.B.</given-names></name><name><surname>de Oliveira</surname><given-names>A.M.</given-names></name></person-group><article-title>Kaurane and pimarane-type diterpenes from the Viguiera species inhibit vascular smooth muscle contractility</article-title><source>Life Sci.</source><year>2006</year><volume>79</volume><fpage>925</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2006.05.015</pub-id><pub-id pub-id-type="pmid">16780894</pub-id></element-citation></ref><ref id="B80-molecules-24-02631"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>A.B.</given-names></name><name><surname>Martins</surname><given-names>C.H.G.</given-names></name><name><surname>Souza</surname><given-names>M.G.M.</given-names></name><name><surname>Furtado</surname><given-names>N.A.J.C.</given-names></name><name><surname>Heleno</surname><given-names>V.C.G.</given-names></name><name><surname>De Sousa</surname><given-names>J.P.B.</given-names></name><name><surname>Rocha</surname><given-names>E.M.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>Cunha</surname><given-names>W.R.</given-names></name><name><surname>Veneziani</surname><given-names>R.C.</given-names></name><etal/></person-group><article-title>Antimicrobial activity of terpenoids from <italic>Copaifera langsdorffii</italic> Desf. against cariogenic bacteria</article-title><source>Phythother. Res.</source><year>2011</year><volume>25</volume><fpage>215</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1002/ptr.3244</pub-id></element-citation></ref><ref id="B81-molecules-24-02631"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f3;&#x0017c;alski</surname><given-names>M.</given-names></name><name><surname>Walencka</surname><given-names>E.</given-names></name><name><surname>R&#x000f3;&#x0017c;alska</surname><given-names>B.</given-names></name><name><surname>Wysoki&#x00144;ska</surname><given-names>H.</given-names></name></person-group><article-title>Antimicrobial activity of diterpenoids from hairy roots of <italic>Salvia sclarea</italic> L.: Salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci</article-title><source>Phytomedicine.</source><year>2007</year><volume>14</volume><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">17190643</pub-id></element-citation></ref><ref id="B82-molecules-24-02631"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>V.K.</given-names></name><name><surname>Tiwari</surname><given-names>N.</given-names></name><name><surname>Gupta</surname><given-names>P.</given-names></name><name><surname>Verma</surname><given-names>S.</given-names></name><name><surname>Pal</surname><given-names>A.</given-names></name><name><surname>Srivastava</surname><given-names>S.K.</given-names></name><name><surname>Darokar</surname><given-names>M.P.</given-names></name></person-group><article-title>A clerodane diterpene from <italic>Polyalthia longifolia</italic> as a modifying agent of the resistance of methicillin resistant <italic>Staphylococcus aureus</italic></article-title><source>Phytomedicine.</source><year>2016</year><volume>23</volume><fpage>654</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2016.03.001</pub-id><pub-id pub-id-type="pmid">27161406</pub-id></element-citation></ref><ref id="B83-molecules-24-02631"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walencka</surname><given-names>E.</given-names></name><name><surname>Rozalska</surname><given-names>S.</given-names></name><name><surname>Wysokinska</surname><given-names>H.</given-names></name><name><surname>Rozalski</surname><given-names>M.</given-names></name><name><surname>Kuzma</surname><given-names>L.</given-names></name><name><surname>Rozalska</surname><given-names>B.</given-names></name></person-group><article-title>Salvipisone and aethiopinone from <italic>Salvia sclarea</italic> hairy roots modulate staphylococcal antibiotic resistance and express anti-biofilm activity</article-title><source>Planta Med.</source><year>2007</year><volume>73</volume><fpage>545</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1055/s-2007-967179</pub-id><pub-id pub-id-type="pmid">17650545</pub-id></element-citation></ref><ref id="B84-molecules-24-02631"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez-Arellanes</surname><given-names>A.</given-names></name><name><surname>Luna-Herrera</surname><given-names>J.</given-names></name><name><surname>Cornejo-Garrido</surname><given-names>J.</given-names></name><name><surname>L&#x000f3;pez-Garc&#x000ed;a</surname><given-names>S.</given-names></name><name><surname>Castro-Mussot</surname><given-names>M.E.</given-names></name><name><surname>Meckes-Fischer</surname><given-names>M.</given-names></name><name><surname>Mata-Espinosa</surname><given-names>D.</given-names></name><name><surname>Marquina</surname><given-names>B.</given-names></name><name><surname>Torres</surname><given-names>J.</given-names></name><name><surname>Hern&#x000e1;ndez-Pando</surname><given-names>R.</given-names></name></person-group><article-title>Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>258</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-258</pub-id><pub-id pub-id-type="pmid">24098949</pub-id></element-citation></ref><ref id="B85-molecules-24-02631"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>W.R.</given-names></name><name><surname>De Matos</surname><given-names>G.X.</given-names></name><name><surname>Souza</surname><given-names>M.G.M.</given-names></name><name><surname>Tozatti</surname><given-names>M.G.</given-names></name><name><surname>Andrade</surname><given-names>E.</given-names></name><name><surname>Silva</surname><given-names>M.L.</given-names></name><name><surname>Martins</surname><given-names>C.H.G.</given-names></name><name><surname>Silva</surname><given-names>R.D.</given-names></name><name><surname>Da Silva Filho</surname><given-names>A.A.</given-names></name></person-group><article-title>Evaluation of the antibacterial activity of the methylene chloride extract of <italic>Miconia ligustroides</italic>, isolated triterpene acids, and ursolic acid derivatives</article-title><source>Pharm. Biol.</source><year>2010</year><volume>48</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.3109/13880200903062648</pub-id><pub-id pub-id-type="pmid">20645834</pub-id></element-citation></ref><ref id="B86-molecules-24-02631"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>X.</given-names></name></person-group><article-title>The in vitro study of ursolic acid and oleanolic acid inhibiting cariogenic microorganisms as well as biofilm</article-title><source>Oral Dis.</source><year>2013</year><volume>19</volume><fpage>494</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1111/odi.12031</pub-id><pub-id pub-id-type="pmid">23114261</pub-id></element-citation></ref><ref id="B87-molecules-24-02631"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>P.Y.</given-names></name><name><surname>Chung</surname><given-names>L.Y.</given-names></name><name><surname>Navaratnam</surname><given-names>P.</given-names></name></person-group><article-title>Potential targets by pentacyclic triterpenoids from <italic>Callicarpa farinosa</italic> against methicillin-resistant and sensitive <italic>Staphylococcus aureus</italic></article-title><source>Fitoterapia.</source><year>2014</year><volume>94</volume><fpage>48</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2014.01.026</pub-id><pub-id pub-id-type="pmid">24508863</pub-id></element-citation></ref><ref id="B88-molecules-24-02631"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>R.E.</given-names></name><name><surname>Diekema</surname><given-names>D.J.</given-names></name><name><surname>Messer</surname><given-names>S.A.</given-names></name><name><surname>Pfaller</surname><given-names>M.A.</given-names></name><name><surname>Klepser</surname><given-names>M.E.</given-names></name></person-group><article-title>Comparison of Etest, chequerboard dilution and time &#x02013; kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species</article-title><source>J. Antimicrob. Chemother.</source><year>2002</year><volume>49</volume><fpage>345</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1093/jac/49.2.345</pub-id><pub-id pub-id-type="pmid">11815578</pub-id></element-citation></ref><ref id="B89-molecules-24-02631"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>T.C.</given-names></name></person-group><article-title>Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</article-title><source>Pharmacol. Rev.</source><year>2006</year><volume>58</volume><fpage>621</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1124/pr.58.3.10</pub-id><pub-id pub-id-type="pmid">16968952</pub-id></element-citation></ref><ref id="B90-molecules-24-02631"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>M.V.</given-names></name><name><surname>Sortino</surname><given-names>M.A.</given-names></name><name><surname>Ivancovich</surname><given-names>J.J.</given-names></name><name><surname>Pellegrino</surname><given-names>J.M.</given-names></name><name><surname>Favier</surname><given-names>L.S.</given-names></name><name><surname>Raimondi</surname><given-names>M.P.</given-names></name><name><surname>Gattuso</surname><given-names>M.A.</given-names></name><name><surname>Zacchino</surname><given-names>S.A.</given-names></name></person-group><article-title>Detection of synergistic combinations of Baccharis extracts with Terbinafine against <italic>Trichophyton rubrum</italic> with high throughput screening synergy assay (HTSS) followed by 3D graphs. Behavior of some of their components</article-title><source>Phytomedicine</source><year>2013</year><volume>13</volume><fpage>1230</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.06.015</pub-id></element-citation></ref><ref id="B91-molecules-24-02631"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacchino</surname><given-names>S.A.</given-names></name><name><surname>Butassi</surname><given-names>E.</given-names></name><name><surname>Di Liberto</surname><given-names>M.</given-names></name><name><surname>Raimondi</surname><given-names>M.</given-names></name><name><surname>Postigo</surname><given-names>A.</given-names></name><name><surname>Sortino</surname><given-names>M.</given-names></name></person-group><article-title>Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs</article-title><source>Phytomedicine</source><year>2017</year><volume>37</volume><fpage>27</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2017.10.018</pub-id><pub-id pub-id-type="pmid">29174958</pub-id></element-citation></ref><ref id="B92-molecules-24-02631"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>K.S.</given-names></name><name><surname>Lim</surname><given-names>Y.R.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>I.S.</given-names></name></person-group><article-title>Terpenes from forests and human health</article-title><source>Toxicol. Res.</source><year>2017</year><volume>2</volume><fpage>97</fpage><pub-id pub-id-type="doi">10.5487/TR.2017.33.2.097</pub-id></element-citation></ref><ref id="B93-molecules-24-02631"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname><given-names>W.</given-names></name><name><surname>Fuchs</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>F.C.</given-names></name></person-group><article-title>Transformation of terpenes into fine chemicals</article-title><source>Eur. J. Lipid Sci. Tech.</source><year>2013</year><volume>1</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/ejlt.201200157</pub-id></element-citation></ref><ref id="B94-molecules-24-02631"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondello</surname><given-names>F.</given-names></name><name><surname>De Bernardis</surname><given-names>F.</given-names></name><name><surname>Girolamo</surname><given-names>A.</given-names></name><name><surname>Cassone</surname><given-names>A.</given-names></name><name><surname>Salvatore</surname><given-names>G.</given-names></name></person-group><article-title>In vivo activity of terpinen-4-ol, the main bioactive component of <italic>Melaleuca alternifolia</italic> Cheel (tea tree) oil against azole-susceptible and-resistant human pathogenic Candida species</article-title><source>BMC infectious diseases</source><year>2006</year><volume>1</volume><elocation-id>158</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-6-158</pub-id></element-citation></ref><ref id="B95-molecules-24-02631"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tona</surname><given-names>L.</given-names></name><name><surname>Mesia</surname><given-names>K.</given-names></name><name><surname>Ngimbi</surname><given-names>N.P.</given-names></name><name><surname>Chrimwami</surname><given-names>B.</given-names></name><name><surname>Okond&#x02019;Ahoka</surname></name><name><surname>Cimanga</surname><given-names>K.</given-names></name><name><surname>Bruyne</surname><given-names>T.D.</given-names></name><name><surname>Apers</surname><given-names>S.</given-names></name><name><surname>Hermans</surname><given-names>N.</given-names></name><name><surname>Totte</surname><given-names>J.</given-names></name><etal/></person-group><article-title>In-vivo antimalarial activity of <italic>Cassia Occidentalism, Morinda morindoides</italic> and <italic>Phyllanthus niruri</italic></article-title><source>Ann. Trop. Med. Parasitol.</source><year>2001</year><volume>1</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1080/00034983.2001.11813614</pub-id></element-citation></ref><ref id="B96-molecules-24-02631"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donald</surname><given-names>P.R.</given-names></name><name><surname>Lamprecht</surname><given-names>J.H.</given-names></name><name><surname>Freestone</surname><given-names>M.</given-names></name><name><surname>Albrecht</surname><given-names>C.F.</given-names></name><name><surname>Bouic</surname><given-names>P.J.</given-names></name><name><surname>Kotze</surname><given-names>D.</given-names></name><name><surname>Van Jaarsveld</surname><given-names>P.P.</given-names></name></person-group><article-title>A randomised placebo-controlled trial of the efficacy of beta-sitosterol and its glucoside as adjuvants in the treatment of pulmonary tuberculosis</article-title><source>Int. J. Tuberc. Lung Dis.</source><year>1997</year><volume>6</volume><fpage>518</fpage><lpage>522</lpage></element-citation></ref><ref id="B97-molecules-24-02631"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlert</surname><given-names>C.</given-names></name><name><surname>Van Rensen</surname><given-names>I.</given-names></name><name><surname>M&#x000e4;rz</surname><given-names>R.</given-names></name><name><surname>Schindler</surname><given-names>G.</given-names></name><name><surname>Graefe</surname><given-names>E.U.</given-names></name><name><surname>Veit</surname><given-names>M.</given-names></name></person-group><article-title>Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans</article-title><source>Planta Med.</source><year>2000</year><volume>6</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1055/s-2000-8616</pub-id></element-citation></ref><ref id="B98-molecules-24-02631"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papada</surname><given-names>E.</given-names></name><name><surname>Gioxari</surname><given-names>A.</given-names></name><name><surname>Brieudes</surname><given-names>V.</given-names></name><name><surname>Amerikanou</surname><given-names>C.</given-names></name><name><surname>Halabalaki</surname><given-names>M.</given-names></name><name><surname>Skaltsounis</surname><given-names>A.L.</given-names></name><name><surname>Smyrnioudis</surname><given-names>I.</given-names></name><name><surname>Kaliora</surname><given-names>A.C.</given-names></name></person-group><article-title>Bioavailability of terpenes and postprandial effect on human antioxidant potential. An open-label study in healthy subjects</article-title><source>Mol. Nutr. Food Res.</source><year>2018</year><volume>3</volume><fpage>1700751</fpage><pub-id pub-id-type="doi">10.1002/mnfr.201700751</pub-id></element-citation></ref><ref id="B99-molecules-24-02631"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>T.</given-names></name><name><surname>Bhat</surname><given-names>S.V.</given-names></name></person-group><article-title>A review on phytosome technology as a novel approach to improve the bioavailability of nutraceuticals</article-title><source>Int. J. Adv. Res. Technol.</source><year>2012</year><volume>3</volume><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="B100-molecules-24-02631"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.K.</given-names></name><name><surname>Yusoff</surname><given-names>K.</given-names></name><name><surname>Mai</surname><given-names>C.W.</given-names></name><name><surname>Lim</surname><given-names>W.M.</given-names></name><name><surname>Yap</surname><given-names>W.S.</given-names></name><name><surname>Lim</surname><given-names>S.H.E.</given-names></name><name><surname>Lai</surname><given-names>K.S.</given-names></name></person-group><article-title>Additivity vs. synergism: Investigation of the additive interaction of cinnamon bark oil and meropenem in combinatory therapy</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1733</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22111733</pub-id></element-citation></ref><ref id="B101-molecules-24-02631"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodede</surname><given-names>O.</given-names></name><name><surname>Shaik</surname><given-names>S.</given-names></name><name><surname>Chenia</surname><given-names>H.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Moodley</surname><given-names>R.</given-names></name></person-group><article-title>Quorum sensing inhibitory potential and in silico molecular docking of flavonoids and novel terpenoids from <italic>Senegalia nigrescens</italic></article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>216</volume><fpage>134</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.01.031</pub-id><pub-id pub-id-type="pmid">29408657</pub-id></element-citation></ref><ref id="B102-molecules-24-02631"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avalos</surname><given-names>M.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name><name><surname>Raaijmakers</surname><given-names>J.M.</given-names></name><name><surname>Garbeva</surname><given-names>P.</given-names></name></person-group><article-title>Healthy scents: Microbial volatiles as new frontier in antibiotic research?</article-title><source>Curr. Opin. Microbiol.</source><year>2018</year><volume>45</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2018.02.011</pub-id><pub-id pub-id-type="pmid">29544125</pub-id></element-citation></ref><ref id="B103-molecules-24-02631"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chudasama</surname><given-names>R.G.</given-names></name><name><surname>Dhanani</surname><given-names>N.J.</given-names></name><name><surname>Amrutiya</surname><given-names>R.M.</given-names></name><name><surname>Chandni</surname><given-names>R.</given-names></name><name><surname>Jayanthi</surname><given-names>G.</given-names></name><name><surname>Karthikeyan</surname><given-names>K.</given-names></name></person-group><article-title>Screening of selected plants from semi-arid region for its phytochemical constituents and antimicrobial activity</article-title><source>J. Pharmacog. Phytochem.</source><year>2018</year><volume>7</volume><fpage>2983</fpage><lpage>2988</lpage></element-citation></ref><ref id="B104-molecules-24-02631"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Bhagat</surname><given-names>M.</given-names></name><name><surname>Sudan</surname><given-names>R.</given-names></name><name><surname>Rajput</surname><given-names>S.</given-names></name><name><surname>Rajput</surname><given-names>K.</given-names></name></person-group><article-title>Analysis of chemical composition of <italic>Cupressus torulosa</italic> (D.Don) essential oil and bioautography guided evaluation of its antimicrobial fraction</article-title><source>Indian J. Exp. Biol.</source><year>2018</year><volume>56</volume><fpage>252</fpage><lpage>257</lpage></element-citation></ref><ref id="B105-molecules-24-02631"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>C&#x000f6;r</surname><given-names>D.</given-names></name><name><surname>Knez</surname><given-names>&#x0017d;.</given-names></name><name><surname>Hrn&#x0010d;i&#x0010d;</surname><given-names>M.K.</given-names></name></person-group><article-title>Antitumour, antimicrobial, antioxidant and antiacetylcholinesterase effect of <italic>Ganoderma Lucidum</italic> terpenoids and polysaccharides: A review</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>649</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23030649</pub-id></element-citation></ref><ref id="B106-molecules-24-02631"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bin Sayeed</surname><given-names>M.</given-names></name><name><surname>Karim</surname><given-names>S.</given-names></name><name><surname>Sharmin</surname><given-names>T.</given-names></name><name><surname>Morshed</surname><given-names>M.</given-names></name></person-group><article-title>Critical analysis on characterization, systemic effect, and therapeutic potential of beta-sitosterol: A plant-derived orphan phytosterol</article-title><source>Medicines</source><year>2016</year><volume>3</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.3390/medicines3040029</pub-id></element-citation></ref><ref id="B107-molecules-24-02631"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>L.L.</given-names></name></person-group><article-title>Challenges of antibacterial discovery</article-title><source>Clin. Microbiol. Rev.</source><year>2011</year><volume>24</volume><fpage>71</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1128/CMR.00030-10</pub-id><pub-id pub-id-type="pmid">21233508</pub-id></element-citation></ref><ref id="B108-molecules-24-02631"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fidyt</surname><given-names>K.</given-names></name><name><surname>Fiedorowicz</surname><given-names>A.</given-names></name><name><surname>Strz&#x00105;da&#x00142;a</surname><given-names>L.</given-names></name><name><surname>Szumny</surname><given-names>A.</given-names></name></person-group><article-title>&#x003b2;-caryophyllene and &#x003b2;-caryophyllene oxide&#x02014;Natural compounds of anticancer and analgesic properties</article-title><source>Cancer Medicine</source><year>2016</year><volume>5</volume><fpage>3007</fpage><lpage>3017</lpage><pub-id pub-id-type="doi">10.1002/cam4.816</pub-id><pub-id pub-id-type="pmid">27696789</pub-id></element-citation></ref><ref id="B109-molecules-24-02631"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Moraes</surname><given-names>M.M.</given-names></name><name><surname>da Camara</surname><given-names>C.A.G.</given-names></name><name><surname>Da Silva</surname><given-names>M.M.C.</given-names></name></person-group><article-title>Comparative toxicity of essential oil and blends of selected terpenes of Ocotea species from Pernambuco, Brazil, against <italic>Tetranychus urticae</italic> Koch</article-title><source>An. Acad. Bras. Cienc.</source><year>2017</year><volume>89</volume><fpage>1417</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.1590/0001-3765201720170139</pub-id><pub-id pub-id-type="pmid">28767894</pub-id></element-citation></ref><ref id="B110-molecules-24-02631"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sparagano</surname><given-names>O.</given-names></name><name><surname>Khallaayoune</surname><given-names>K.</given-names></name><name><surname>Duvallet</surname><given-names>G.</given-names></name><name><surname>Nayak</surname><given-names>S.</given-names></name><name><surname>George</surname><given-names>D.</given-names></name></person-group><article-title>Comparing terpenes from plant essential oils as pesticides for the poultry red mite (<italic>Dermanyssus gallinae</italic>)</article-title><source>Transbound. Emerg. Dis.</source><year>2013</year><volume>60</volume><fpage>150</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1111/tbed.12138</pub-id><pub-id pub-id-type="pmid">24589115</pub-id></element-citation></ref><ref id="B111-molecules-24-02631"><label>111.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Van der Werf</surname><given-names>M.J.</given-names></name><name><surname>de Bont</surname><given-names>J.A.</given-names></name><name><surname>Leak</surname><given-names>D.J.</given-names></name></person-group><article-title>Opportunities in microbial biotransformation of monoterpenes</article-title><source>Biotechnology of Aroma Compounds</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>1997</year><fpage>147</fpage><lpage>177</lpage></element-citation></ref></ref-list></back><floats-group><fig id="molecules-24-02631-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Overall mechanisms of antibiotic resistance in bacteria. Picture adapted from [<xref rid="B17-molecules-24-02631" ref-type="bibr">17</xref>].</p></caption><graphic xlink:href="molecules-24-02631-g001"/></fig><fig id="molecules-24-02631-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Postulated mode of action of terpene/terpenoids on antibiotic resistance pathogens and as combination therapies.</p></caption><graphic xlink:href="molecules-24-02631-g002"/></fig><table-wrap id="molecules-24-02631-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-24-02631-t001_Table 1</object-id><label>Table 1</label><caption><p>Essential oils extracted from plant against tested pathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants spp.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Common Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pathogens Tested</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MIC/Sensitivity/Inhibition Zone</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Citation</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Eugenia caryophyllata</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Clove</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Burkholderia cepacia</italic> complex</td><td align="center" valign="middle" rowspan="1" colspan="1">ES</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B35-molecules-24-02631" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Origanum vulgare</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Oregano</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>B. cepacia</italic> complex</td><td align="center" valign="middle" rowspan="1" colspan="1">ES</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B35-molecules-24-02631" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Thymus vulgaris</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Thyme</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>B. cepacia</italic> complex</td><td align="center" valign="middle" rowspan="1" colspan="1">ES</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B35-molecules-24-02631" ref-type="bibr">35</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">
<italic>Eucalyptus camadulensis</italic>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Eucalyptus</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Streptococcus pyogenes</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1 mg mL<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B36-molecules-24-02631" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Fusarium oxysporum</italic> f. sp. <italic>lycopersici</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">15.93% to 72.5%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-molecules-24-02631" ref-type="bibr">37</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" colspan="1">
<italic>Mentha spicata</italic>
</td><td rowspan="4" align="center" valign="middle" colspan="1">Spearmint</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>S. pyogenes</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2 mg mL<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B36-molecules-24-02631" ref-type="bibr">36</xref>] </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">21 mm at 150 &#x000b5;L</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-molecules-24-02631" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Salmonella thyphi</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">13 mm at 150 &#x000b5;L</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12 mm at 150 &#x000b5;L</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">
<italic>Cymbopogon citratus</italic>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Lemongrass</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Acinetobacter baumannii</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65% (v/v)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B39-molecules-24-02631" ref-type="bibr">39</xref>] </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>F. oxysporum</italic> f. sp. <italic>lycopersici</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">250 ppm</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-molecules-24-02631" ref-type="bibr">37</xref>] </td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">
<italic>Syzygium aromaticum</italic>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Clove</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Candida albicans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">360 &#x000b5;g mL<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B40-molecules-24-02631" ref-type="bibr">40</xref>] </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>F. oxysporum</italic> f. sp. <italic>lycopersici</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">125 ppm</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-molecules-24-02631" ref-type="bibr">37</xref>] </td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">
<italic>Pelargonium graveolens</italic>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Geranium</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>B. cepacia</italic> complex</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4% (v/v)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B41-molecules-24-02631" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Prototheca zopfii</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 to 4.0 &#x000b5;L mL<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B42-molecules-24-02631" ref-type="bibr">42</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">
<italic>Laurus nobilis</italic>
</td><td rowspan="3" align="center" valign="middle" colspan="1">Bay laurel</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>S. typhimurium</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3 % (v/v)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B43-molecules-24-02631" ref-type="bibr">43</xref>] </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1 % (v/v)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B44-molecules-24-02631" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Candida</italic> spp.</td><td align="center" valign="middle" rowspan="1" colspan="1">250 to 500 &#x000b5;g mL<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Melaleuca alternifolia</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Tea tree</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Campylobacter</italic> spp.</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-molecules-24-02631" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Leptospermum petersonii</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Manuka</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Campylobacter</italic> spp.</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-molecules-24-02631" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Backhousia citriodora</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Lemon myrtle</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Campylobacter</italic> spp.</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-molecules-24-02631" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">
<italic>Lavandula angustifolia</italic>
</td><td rowspan="3" align="center" valign="middle" colspan="1">Lavender</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2 mg mL<sup>&#x02212;1</sup></td><td rowspan="3" align="center" valign="middle" colspan="1">[<xref rid="B46-molecules-24-02631" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Pseudomonas aeruginosa</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2 mg mL<sup>&#x02212;1</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>C. albicans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3 mg mL<sup>&#x02212;1</sup></td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">
<italic>Mentha x piperita</italic>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Peppermint</td><td rowspan="2" align="center" valign="middle" colspan="1"><italic>Clostridium perfringens Fusarium oxysporum</italic> f. sp. <italic>lycopersici</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">10 mg mL<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B47-molecules-24-02631" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">500 ppm</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-molecules-24-02631" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Chamaemelum nobile</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Roman chamomile</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Porphyromonas gingivalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">20.5 &#x000b1; 0.5 mm</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-molecules-24-02631" ref-type="bibr">48</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">
<italic>Origanum majorana</italic>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Marjoram</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Micrococcus luteus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.097 mg mL<sup>&#x02212;1</sup></td><td rowspan="2" align="center" valign="middle" colspan="1">[<xref rid="B49-molecules-24-02631" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Vibrio alginolyticus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.39 mg mL<sup>&#x02212;1</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Foeniculum vulgare</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Fennel</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Candida</italic> spp.</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56 to 12.48 mg mL<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-24-02631" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Pinus sylvestris</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Pine</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Pseudomonas</italic> spp.</td><td align="center" valign="middle" rowspan="1" colspan="1">4.33 &#x000b1; 0.58 mm</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B51-molecules-24-02631" ref-type="bibr">51</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">
<italic>Cedrus atlantica</italic>
</td><td rowspan="3" align="center" valign="middle" colspan="1">Cedarwoood</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4 &#x000b5;L mL<sup>&#x02212;1</sup></td><td rowspan="3" align="center" valign="middle" colspan="1">[<xref rid="B52-molecules-24-02631" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Bacillus subtilis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 &#x000b5;L mL<sup>&#x02212;1</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Bacillus cereus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4 &#x000b5;L mL<sup>&#x02212;1</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aniba rosaeodora</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rosewood</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trichophyton mentagrophytes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002 M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-molecules-24-02631" ref-type="bibr">53</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>ES: extremely sensitive.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-24-02631-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-24-02631-t002_Table 2</object-id><label>Table 2</label><caption><p>Summary of antimicrobial activity effects of some terpenoid class.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Terpenoids Class</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical Compounds</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tested Microorganism</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial Effect</th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="11" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Monoterpenes and monoterpenoids</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol<break/>Thymol<break/>Geraniol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Resistant <italic>Enterobacter aerogenes</italic></td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Efflux pump inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B60-molecules-24-02631" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Linalyl acetate<break/>(+)- Menthol<break/>Thymol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
<break/>
<italic>E. coli</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-molecules-24-02631" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol<break/>Trans-cinnamaldehyde<break/>(+)-Carvone</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
<break/>
<italic>S. typhimurium</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-molecules-24-02631" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Terpinen-4-ol<break/>&#x003b3;-Terpinene<break/>&#x003b1;-Terpinene<break/>Terpinolene<break/>&#x003b1;-Pinene 1,8-Cineole<break/>&#x003c1;-Cymene<break/>(+)-Limonene<break/>&#x003b2;-Myrcene<break/>(+)-&#x003b2;-Pinene<break/>(&#x000b1;)-Linalool<break/>&#x003b1;-Phellandrene<break/>&#x003b1;-Terpinoel</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>T. mentagrophytes Trichophyton violaceum Microsporium gypseum Histoplasma capsulatum Blastomyces dermatitidis</italic>&#x02026;etc.</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-molecules-24-02631" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol<break/>Eugenol<break/>Thymol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Acinetobacter calcoacetica</italic>
<break/>
<italic>Aeromonas hydrophila</italic>
<break/>
<italic>B. subtilis</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-molecules-24-02631" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Borneol<break/>d-3-Carene<break/>Carvacrol<break/>Carvacrol methyl ester<break/><italic>cis/trans</italic> Citral<break/>Eugenol<break/>Geraniol<break/>Geranyl acetate<break/><italic>cis</italic>-hex-3-en-1-ol R(+)Limonene<break/>(2)-Linalool<break/>Menthone<break/>Nerol<break/>&#x003b1;-Pinene<break/>&#x003b2;-Pinene<break/>(+)sabinene<break/>&#x003b1;-Terpinene<break/>Terpinen-4-ol<break/>&#x003b1;-terpineole<break/>(&#x02212;)-Thujone<break/>Thymol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. aureus</italic><break/><italic>E. coli</italic><break/><italic>Salmonella typhia</italic><break/><italic>S. typhimurium</italic><break/><italic>Salmonella enteritidis</italic><break/><italic>A. hydrophila</italic><break/><italic>Yersinia</italic> sp. <italic>Vibrio anguillarum</italic><break/><italic>Shigella</italic> sp. <italic>Vibrio parahaemolyticus C. albicans</italic><break/><italic>Penicillium expansum</italic><break/><italic>Aspergillus niger</italic>&#x02026;etc.</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-molecules-24-02631" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S.aureus</italic>
<break/>
<italic>S. typhimurium</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Biofilm inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-molecules-24-02631" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Linalool</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Resistant <italic>K. pneumoniae carbapenemase</italic> (KPC)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell membrane disruption</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-molecules-24-02631" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpinen-4-ol<break/>&#x003b1;-Terpineol<break/>1, 8-Cineole<break/>Linalool</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. niger</italic>
<break/>
<italic>Botrytis cinerea</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-molecules-24-02631" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-Terpinene<break/>&#x003b3;-Terpinene<break/>&#x003b1;-Pinene<break/>&#x003c1;-Cymene<break/>Terpinen-4-ol<break/>&#x003b1;-Terpineol<break/>Thymol<break/>Citral<break/>1, 8-Cineole<break/>Borneol<break/>Bornyl acetate<break/>Isoborneol<break/>1, 8-Cineole Thujone<break/>Camphor</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Herpes simplex virus</italic> type 1 (HSV-1)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-molecules-24-02631" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymol<break/>Carvacrol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tobacco mosaic virus</italic> (TMV)<break/><italic>Cucumber mosaic virus</italic> (CMV)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-molecules-24-02631" ref-type="bibr">70</xref>]</td></tr><tr><td rowspan="6" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Sesquiterpenes and Sesquiterpenoids</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x003b1;-Acetoxy-6&#x003b2;, 9&#x003b2;-dibenzoyloxy-dihydro-&#x003b2;-agarofuran</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bacillus</italic> spp.</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-molecules-24-02631" ref-type="bibr">71</xref>]</td></tr><tr><td rowspan="3" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Farnesol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Streptococcus mutans Streptococcus sobrinus</italic>
</td><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Biofilm formation inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-molecules-24-02631" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
<break/>
<italic>S. epidermidis</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-molecules-24-02631" ref-type="bibr">73</xref>]<break/>[<xref rid="B74-molecules-24-02631" ref-type="bibr">74</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>B. pseudomallei</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Potentiation effect&#x02014;combination therapy</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-molecules-24-02631" ref-type="bibr">75</xref>]</td></tr><tr><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Xanthorrhizol</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Staphylococcus mutans</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction of cell adherence ability</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-molecules-24-02631" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mycobacterium smegmatis</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-molecules-24-02631" ref-type="bibr">77</xref>]</td></tr><tr><td rowspan="6" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Diterpenes and diterpenoids</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">(-)-Carvone<break/>Thymol<break/>Dihydrocarveol<break/>(-)-Perilla alcohol<break/>Carvacrol<break/>(-)-Carveol&#x02026;etc.</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
<break/>
<italic>E. coli</italic>
<break/>
<italic>S. aureus</italic>
<break/>
<italic>C. albicans</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-molecules-24-02631" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ent-kaurane<break/>Ent-pimarane</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Dental carries pathogens</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-molecules-24-02631" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Salvipisone</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
<break/>
<italic>S. epidermidis</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bacterial cell adherence prevention<break/>Biofilm development inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-molecules-24-02631" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">16&#x003b1;Hydroxycleroda-3, 13 (14)-Z-dien-15, 16-olide (CD)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic potentiation<break/>Efflux pump modulation</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-molecules-24-02631" ref-type="bibr">82</xref>]</td></tr><tr><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Salvipisone<break/>Aethiopinone</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus Enterococcus faecalis</italic>
<break/>
<italic>S. epidermidis</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Biofilm production inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-molecules-24-02631" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA<break/>MRSE</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Synergistic activity alongside antibiotic</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-molecules-24-02631" ref-type="bibr">83</xref>]</td></tr><tr><td rowspan="8" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Triterpenes and triterpenoids</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">24, 24-Dimethyl-5&#x003b2;-tirucall-9</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Tubercular strains</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B11-molecules-24-02631" ref-type="bibr">11</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">25-Dien-3-one<break/>Oleanic acid (OA)<break/>Bonianic acid A<break/>Bonianic acid B</td><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">
<italic>Mycobacterium tuberculosis</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Synergistic activity alongside antibiotic</td><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">[<xref rid="B2-molecules-24-02631" ref-type="bibr">2</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">OA<break/>Ergosterol peroxide<break/>Ursolic acid (UA)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Synergistic activity&#x02014;combination therapy</td></tr><tr><td rowspan="3" align="center" valign="top" style="border-bottom:solid thin" colspan="1">OA<break/>UA</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>B. cereus</italic>
<break/>
<italic>Vibrio cholerae</italic>
<break/>
<italic>S. choleraesuis</italic>
<break/>
<italic>K. pneumoniae</italic>
<break/>
<italic>S. pneumoniae</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-molecules-24-02631" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Planktonic cariogenic microorganism<break/><italic>S. mutans</italic><break/><italic>S. sobrinus</italic></td><td rowspan="2" align="center" valign="top" style="border-bottom:solid thin" colspan="1">Biofilm inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-molecules-24-02631" ref-type="bibr">86</xref>]<break/>[<xref rid="B31-molecules-24-02631" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Listeria monocytogenes</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-molecules-24-02631" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">OA</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumanii</italic>
</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic potentiation</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B4-molecules-24-02631" ref-type="bibr">4</xref>]</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Amyrin<break/>Betulinic acid<break/>Betulinaldehyde</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA<break/>MMSA</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-molecules-24-02631" ref-type="bibr">87</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>